Agilent Technologies, Inc. (A)
Santa Clara, CA, US
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
3 articles
- Agilent Strengthens Biopharma Growth Prospects With AI Expansion Zacks Investment Research
- Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis Business Wire
- Alpha and Omega Semiconductor Unveils AmpStack™ Packaging: A Leap Forward in MOSFET Power Density GuruFocus
No mergers or acquisitions recorded for this company.
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| S&P 500 | 2000-06-02 | — | Active |
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.65% | +0.70% | +0.18% | -4.57% | -24.54% | -14.87% | +4.11% | -1.61% | -15.78% | +152.79% | +302.19% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 5 | +1 |
| Buy | 10 | 0 |
| Hold | 4 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 2 |
154.50
+14.7%
|
| Last Quarter | 4 |
149.75
+11.2%
|
| Last Year | 19 |
164.79
+22.4%
|
| All Time | 37 |
155.95
+15.8%
|
-
Revenue growth Medical - Diagnostics & Research: +7.9%+6.7% Q2'26: +10.0% (vs Q2'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%+3.2% Q2'26: +60.0% (vs Q2'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%+17.9% Q2'26: +20.2% (vs Q2'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%+22.3% ★ Q2'26: +0.0% (vs Q2'25)
-
ROIC Medical - Diagnostics & Research: +5.2%+16.9% ★ Q2'26: +0.0% (vs Q2'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%-2.4% ★ Q2'26: -0.4% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×1.83× Q2'26: 3.15× (vs Q2'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Oct 2011 actual |
Oct 2012 actual |
Oct 2013 actual |
Oct 2014 actual |
Oct 2015 actual |
Oct 2016 actual |
Oct 2017 actual |
Oct 2018 actual |
Oct 2019 actual |
Oct 2020 actual |
Oct 2021 actual |
Oct 2022 actual |
Oct 2023 actual |
Oct 2024 actual |
Oct 2025 actual |
Oct 2026 12 Rev. Ana. 11 EPS Ana. |
Oct 2027 13 Rev. Ana. 11 EPS Ana. |
Oct 2028 12 Rev. Ana. 5 EPS Ana. |
Oct 2029 6 Rev. Ana. 1 EPS Ana. |
Oct 2030 7 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
6.62B
est: 6.19B (+6.9%)
|
6.86B
est: 6.71B (+2.2%)
|
3.89B
est: 5.90B (-34.0%)
|
4.05B
est: 4.01B (+1.0%)
|
4.04B
est: 4.04B (0.0%)
|
4.20B
est: 4.16B (+1.0%)
|
4.47B
est: 4.45B (+0.4%)
|
4.91B
est: 4.88B (+0.8%)
|
5.16B
est: 5.13B (+0.7%)
|
5.34B
est: 5.26B (+1.6%)
|
6.32B
est: 6.32B (+0.0%)
|
6.85B
est: 6.76B (+1.3%)
|
6.83B
est: 6.82B (+0.2%)
|
6.51B
est: 6.48B (+0.4%)
|
6.95B
est: 6.92B (+0.4%)
|
7.39B
7.35B – 7.42B
+6.9% YoY
|
7.84B
7.76B – 7.90B
+6.1% YoY
|
8.36B
8.36B – 8.36B
+6.6% YoY
|
8.82B
8.74B – 8.87B
+5.4% YoY
|
9.32B
9.23B – 9.38B
+5.7% YoY
|
| EBITDA |
1.37B
est: 1.27B (+7.6%)
|
1.45B
est: 1.41B (+2.7%)
|
758.00M
est: 1.25B (-39.5%)
|
723.00M
est: 1.46B (-50.4%)
|
799.00M
est: 946.66M (-15.6%)
|
863.00M
est: 1.04B (-17.4%)
|
1.10B
est: 1.08B (+1.7%)
|
1.23B
est: 1.94B (-36.6%)
|
1.23B
est: 1.39B (-11.6%)
|
1.23B
est: 1.46B (-15.6%)
|
1.76B
est: 1.73B (+2.1%)
|
1.91B
est: 1.85B (+2.8%)
|
1.70B
est: 2.04B (-16.5%)
|
1.87B
est: 1.76B (+6.4%)
|
1.84B
est: 1.88B (-2.4%)
|
2.01B
2.00B – 2.02B
+6.9% YoY
|
2.13B
2.11B – 2.15B
+6.1% YoY
|
2.27B
2.27B – 2.27B
+6.6% YoY
|
2.39B
2.37B – 2.41B
+5.4% YoY
|
2.53B
2.51B – 2.55B
+5.7% YoY
|
| EBIT |
1.12B
est: 996.07M (+12.2%)
|
1.14B
est: 1.09B (+4.9%)
|
386.00M
est: 890.58M (-56.7%)
|
339.00M
est: 1.08B (-68.5%)
|
546.00M
est: 646.37M (-15.5%)
|
616.00M
est: 746.09M (-17.4%)
|
882.00M
est: 829.28M (+6.4%)
|
1.02B
est: 1.49B (-31.5%)
|
993.00M
est: 1.06B (-6.6%)
|
920.00M
est: 996.15M (-7.6%)
|
1.44B
est: 1.32B (+9.2%)
|
1.59B
est: 1.47B (+7.9%)
|
1.43B
est: 1.62B (-11.4%)
|
1.62B
est: 1.48B (+9.4%)
|
1.55B
est: 1.58B (-2.0%)
|
1.69B
1.68B – 1.69B
+6.9% YoY
|
1.79B
1.77B – 1.80B
+6.1% YoY
|
1.91B
1.91B – 1.91B
+6.6% YoY
|
2.01B
1.99B – 2.02B
+5.4% YoY
|
2.12B
2.11B – 2.14B
+5.7% YoY
|
| Net Income |
1.01B
est: 945.36M (+7.0%)
|
1.15B
est: 1.12B (+3.4%)
|
724.00M
est: 679.77M (+6.5%)
|
549.00M
est: 596.45M (-8.0%)
|
401.00M
est: 491.46M (-18.4%)
|
460.00M
est: 561.03M (-18.0%)
|
684.00M
est: 672.36M (+1.7%)
|
316.00M
est: -438.87M (+172.0%)
|
1.07B
est: 1.14B (-6.2%)
|
719.00M
est: 846.92M (-15.1%)
|
1.21B
est: 1.18B (+2.5%)
|
1.25B
est: 1.28B (-1.7%)
|
1.24B
est: 1.24B (-0.2%)
|
1.29B
est: 1.49B (-13.4%)
|
1.30B
est: 1.58B (-17.7%)
|
1.69B
1.68B – 1.70B
+6.9% YoY
|
1.86B
1.83B – 1.90B
+10.1% YoY
|
2.06B
1.93B – 2.20B
+10.8% YoY
|
2.28B
2.25B – 2.30B
+10.5% YoY
|
2.47B
2.44B – 2.49B
+8.1% YoY
|
| SGA |
1.81B
est: 1.68B (+7.7%)
|
1.82B
est: 1.77B (+2.5%)
|
1.88B
est: 1.76B (+6.7%)
|
2.04B
est: 2.71B (-24.5%)
|
1.19B
est: 1.49B (-20.3%)
|
1.25B
est: 1.52B (-17.7%)
|
1.23B
est: 1.21B (+1.6%)
|
1.37B
est: 2.17B (-36.8%)
|
1.46B
est: 1.66B (-11.9%)
|
1.50B
est: 1.79B (-16.4%)
|
1.62B
est: 1.60B (+1.3%)
|
1.64B
est: 1.60B (+2.6%)
|
1.63B
est: 1.76B (-6.9%)
|
1.52B
est: 1.57B (-3.5%)
|
1.71B
est: 1.68B (+1.8%)
|
1.79B
1.78B – 1.80B
+6.9% YoY
|
1.90B
1.88B – 1.92B
+6.1% YoY
|
2.03B
2.03B – 2.03B
+6.6% YoY
|
2.14B
2.12B – 2.15B
+5.4% YoY
|
2.26B
2.24B – 2.28B
+5.7% YoY
|
| EPS |
2.92
est: 2.57 (+13.6%)
|
3.31
est: 2.98 (+11.1%)
|
2.12
est: 2.55 (-16.9%)
|
1.65
est: 4.07 (-59.4%)
|
1.20
est: 1.71 (-29.7%)
|
1.42
est: 1.91 (-25.6%)
|
2.12
est: 2.32 (-8.5%)
|
0.98
est: 2.72 (-63.9%)
|
3.41
est: 3.08 (+10.6%)
|
2.33
est: 3.24 (-28.1%)
|
3.98
est: 4.31 (-7.7%)
|
4.19
est: 5.07 (-17.4%)
|
4.22
est: 5.41 (-22.0%)
|
4.44
est: 5.24 (-15.3%)
|
4.59
est: 5.57 (-17.6%)
|
5.97
5.92 – 6.00
+7.1% YoY
|
6.55
6.44 – 6.68
+9.7% YoY
|
7.27
6.79 – 7.75
+11.1% YoY
|
8.03
7.94 – 8.10
+10.4% YoY
|
8.68
8.58 – 8.75
+8.1% YoY
|
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-26 | Baird | Outperform | Outperform | Maintain |
| 2026-04-28 | Keybanc | Sector Weight | Sector Weight | Maintain |
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-01 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | FMR Corp. | 32.77M | 8.05% | 4.26M | — | 32.77M | — | HC | Delaware | 2007-02-14 | ↗ |
| 2 | (1) BlackRock, Inc. | 30.08M | 10.00% | 25.90M | — | 30.08M | — | HC | Delaware | 2022-04-08 | ↗ |
| 3 | Davis Selected Advisers, L.P. | 28.23M | 8.09% | 22.40M | — | — | 22.40M | IA | Colorado | 2010-02-12 | ↗ |
| 4 | The Vanguard Group - 23-1945930 | 24.27M | 8.04% | — | — | 23.01M | 1.26M | IA | Pennsylvania | 2022-02-09 | ↗ |
| 5 | 943112180 | 23.43M | 4.65% | 19.78M | — | 23.43M | — | BK | U.S.A. | 2006-01-26 | ↗ |
| 6 | Abigail P. Johnson | 23.19M | 6.92% | — | — | 23.19M | — | IN | United States of America | 2015-02-13 | ↗ |
| 7 | Edward C. Johnson 3d | 23.19M | 6.92% | — | — | 23.19M | — | IN | United States of America | 2015-02-13 | ↗ |
| 8 | 52-0556948 | 21.69M | 7.10% | 8.60M | — | — | — | IA | Maryland | 2022-02-14 | ↗ |
| 9 | BlackRock for purposes of Schedule 13G filings. | 19.85M | 5.69% | 19.85M | — | 19.85M | — | HC | Delaware | 2010-01-29 | ↗ |
| 10 | Identification #52-2069785 (formerly 13-2631108) | 16.74M | 11.00% | 10.27M | — | — | 16.74M | IA | Delaware | 2012-02-10 | ↗ |
| 11 | 04-2747644 | 15.59M | 5.40% | 15.13M | — | 15.59M | — | IA | Delaware | 2024-11-12 | ↗ |
| 12 | 77-0518772 | 13.14M | 56.60% | — | 13.14M | — | 10.00 | CO | State of Delaware | 2007-04-16 | ↗ |
| 13 | BARCLAYS GLOBAL INVESTORS, LTD | 3.30M | 0.66% | 3.05M | — | 3.30M | — | BK | England | 2006-01-26 | ↗ |
| 14 | BARCLAYS GLOBAL FUND ADVISORS | 2.51M | 0.50% | 2.46M | — | 2.51M | — | IA | U.S.A. | 2006-01-26 | ↗ |
| 15 | BARCLAYS GLOBAL INVESTORS JAPAN TRUST AND BANKING COMPANY LIMITED | 385.5K | 0.08% | 385.5K | — | 385.5K | — | BK | Japan | 2006-01-26 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 34.11M +67.1K (+0.2%) | 4.64B +271.9M (+6.2%) | 12.05% +0.024 pp | 0.07% +0.002 pp | USD67.12 +102.7% | 84 qtrs — |
| 2 | BLACKROCK, INC. | 25.87M -276.0K (-1.1%) | 3.52B +164.3M (+4.9%) | 9.14% -0.098 pp | 0.06% +0.001 pp | USD148.22 -8.2% | 6 qtrs — |
| 3 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 14.15M +1.7M (+13.8%) | 1.93B +329.1M (+20.6%) | 5.00% +0.605 pp | 0.62% +0.126 pp | USD127.34 +6.9% | 24 qtrs — |
| 4 | STATE STREET CORP | 12.68M +241.0K (+1.9%) | 1.73B +125.8M (+7.9%) | 4.48% +0.085 pp | 0.06% +0.002 pp | USD48.60 +180.0% | 51 qtrs — |
| 5 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 8.14M -4.2K (-0.1%) | 1.11B +62.3M (+6.0%) | 2.88% -0.002 pp | 0.70% +0.060 pp | USD121.15 +12.3% | 14 qtrs — |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 7.59M -1.8M (-19.1%) | 1.03B -171.2M (-14.2%) | 2.68% -0.633 pp | 0.18% -0.030 pp | USD111.53 +22.0% | 61 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 7.43M +25.1K (+0.3%) | 1.01B +60.5M (+6.4%) | 2.62% +0.009 pp | 0.06% +0.002 pp | USD76.26 +78.4% | 78 qtrs — |
| 8 | DEUTSCHE BANK AG\ | 5.55M -29.3K (-0.5%) | 754.93M +39.1M (+5.5%) | 1.96% -0.010 pp | 0.25% +0.006 pp | USD102.23 +33.1% | 50 qtrs — |
| 9 | MORGAN STANLEY | 5.04M +692.2K (+15.9%) | 686.05M +127.8M (+22.9%) | 1.78% +0.245 pp | 0.04% +0.007 pp | USD126.92 +7.2% | 51 qtrs — |
| 10 | PICTET ASSET MANAGEMENT HOLDING SA | 4.66M -593.3K (-11.3%) | 634.77M -40.1M (-5.9%) | 1.65% -0.210 pp | 0.62% -0.034 pp | USD113.76 +19.6% | 10 qtrs — |
| 11 | GENERATION INVESTMENT MANAGEMENT LLP | 4.18M -2.2M (-34.3%) | 568.81M -247.2M (-30.3%) | 1.48% -0.770 pp | 3.95% -1.461 pp | USD136.25 -0.1% | 6 qtrs — |
| 12 | NORGES BANK | 4.04M +4.0M (+100.0%) | 549.16M +549.2M (+100.0%) | 1.43% +1.426 pp | 0.06% +0.059 pp | USD136.07 +0.0% | 1 qtrs NEW |
| 13 | STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 3.83M +— (+0.0%) | 520.51M +29.5M (+6.0%) | 1.35% +0.000 pp | 0.41% -0.001 pp | USD49.52 +174.8% | 103 qtrs — |
| 14 | NORTHERN TRUST CORP | 3.79M -88.6K (-2.3%) | 515.29M +17.9M (+3.6%) | 1.34% -0.031 pp | 0.07% +0.002 pp | USD68.90 +97.5% | 51 qtrs — |
| 15 | CANTILLON CAPITAL MANAGEMENT LLC | 3.12M +23.5K (+0.8%) | 423.94M +27.1M (+6.8%) | 1.10% +0.008 pp | 2.29% +0.107 pp | USD59.78 +127.6% | 41 qtrs — |
| 16 | GOLDMAN SACHS GROUP INC | 3.08M +555.3K (+22.0%) | 419.72M +95.1M (+29.3%) | 1.09% +0.196 pp | 0.05% +0.012 pp | USD127.20 +7.0% | 73 qtrs — |
| 17 | BANK OF NEW YORK MELLON CORP | 2.86M +845.7K (+42.0%) | 388.86M +130.6M (+50.6%) | 1.01% +0.299 pp | 0.07% +0.019 pp | USD75.39 +80.5% | 66 qtrs — |
| 18 | IMPAX ASSET MANAGEMENT GROUP PLC | 2.60M -366.2K (-12.4%) | 353.18M -27.0M (-7.1%) | 0.92% -0.129 pp | 2.21% -0.009 pp | USD103.99 +30.8% | 30 qtrs — |
| 19 | INVESCO LTD. | 2.59M +627.8K (+32.0%) | 352.52M +100.6M (+39.9%) | 0.92% +0.222 pp | 0.05% +0.014 pp | USD118.73 +14.6% | 57 qtrs — |
| 20 | UBS ASSET MANAGEMENT AMERICAS INC | 2.54M -476.4K (-15.8%) | 345.11M -41.6M (-10.7%) | 0.90% -0.168 pp | 0.07% -0.011 pp | USD104.74 +29.9% | 90 qtrs — |
| 21 | TROY ASSET MANAGEMENT LTD | 2.41M +1.7K (+0.1%) | 327.37M +18.8M (+6.1%) | 0.85% +0.001 pp | 8.44% +0.514 pp | USD106.12 +28.2% | 25 qtrs — |
| 22 | JPMORGAN CHASE & CO | 2.28M +18.9K (+0.8%) | 309.67M +20.0M (+6.9%) | 0.80% +0.007 pp | 0.02% +0.002 pp | USD126.84 +7.3% | 51 qtrs — |
| 23 | AMERIPRISE FINANCIAL INC | 2.19M -513.6K (-19.0%) | 298.67M -49.0M (-14.1%) | 0.78% -0.182 pp | 0.07% -0.012 pp | USD121.22 +12.3% | 55 qtrs — |
| 24 | LEGAL & GENERAL GROUP PLC | 2.14M -48.5K (-2.2%) | 291.35M +10.3M (+3.7%) | 0.76% -0.017 pp | 0.06% +0.002 pp | USD69.67 +95.3% | 75 qtrs — |
| 25 | QUBE RESEARCH & TECHNOLOGIES LTD | 2.12M +1.3M (+169.7%) | 288.58M +187.6M (+185.9%) | 0.75% +0.472 pp | 0.29% +0.189 pp | USD129.78 +4.8% | 23 qtrs — |
| 26 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2.06M -81.1K (-3.8%) | 280.71M +5.5M (+2.0%) | 0.73% -0.029 pp | 0.78% +0.071 pp | USD136.22 -0.1% | 31 qtrs — |
| 27 | DIMENSIONAL FUND ADVISORS LP | 1.92M +115.2K (+6.4%) | 261.76M +29.7M (+12.8%) | 0.68% +0.041 pp | 0.05% +0.005 pp | USD97.62 +39.4% | 51 qtrs — |
| 28 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.82M +27.0K (+1.5%) | 247.78M +17.5M (+7.6%) | 0.64% +0.010 pp | 0.04% +0.002 pp | USD69.80 +94.9% | 100 qtrs — |
| 29 | NORDEA INVESTMENT MANAGEMENT AB | 1.77M -106.3K (-5.7%) | 242.98M +7.5M (+3.2%) | 0.63% -0.038 pp | 0.21% +0.002 pp | USD132.00 +3.1% | 88 qtrs — |
| 30 | VAN ECK ASSOCIATES CORP | 1.61M -1.4M (-46.4%) | 219.43M -166.6M (-43.2%) | 0.57% -0.493 pp | 0.18% -0.177 pp | USD120.52 +12.9% | 32 qtrs — |
| 31 | BALYASNY ASSET MANAGEMENT L.P. | 1.41M +928.8K (+192.0%) | 192.20M +130.1M (+209.6%) | 0.50% +0.328 pp | 0.24% +0.165 pp | USD133.44 +2.0% | 7 qtrs — |
| 32 | BANK OF AMERICA CORP /DE/ | 1.37M +150.9K (+12.4%) | 186.66M +30.0M (+19.1%) | 0.48% +0.053 pp | 0.01% +0.003 pp | USD104.51 +30.2% | 52 qtrs — |
| 33 | AQR CAPITAL MANAGEMENT LLC | 1.37M -312.1K (-18.6%) | 186.14M -23.2M (-11.1%) | 0.48% -0.110 pp | 0.10% -0.037 pp | USD120.09 +13.3% | 63 qtrs — |
| 34 | PRIMECAP MANAGEMENT CO/CA/ | 1.34M -75.3K (-5.3%) | 181.98M +664.1K (+0.4%) | 0.47% -0.027 pp | 0.14% -0.001 pp | USD41.60 +227.1% | 93 qtrs — |
| 35 | DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 1.19M +776.8K (+187.0%) | 162.22M +108.9M (+204.3%) | 0.42% +0.275 pp | 0.14% +0.093 pp | USD133.64 +1.8% | 25 qtrs — |
| 36 | FMR LLC | 1.15M +33.3K (+3.0%) | 156.69M +13.2M (+9.2%) | 0.41% +0.012 pp | 0.01% +0.001 pp | USD134.92 +0.9% | 70 qtrs — |
| 37 | FRANKLIN RESOURCES INC | 1.12M -24.3K (-2.1%) | 151.82M +5.5M (+3.8%) | 0.39% -0.009 pp | 0.04% +0.001 pp | USD75.53 +80.2% | 51 qtrs — |
| 38 | TD ASSET MANAGEMENT INC | 1.05M -51.5K (-4.7%) | 143.39M +1.5M (+1.1%) | 0.37% -0.018 pp | 0.12% +0.000 pp | USD107.55 +26.5% | 51 qtrs — |
| 39 | ROBECO SCHWEIZ AG | 1.05M -115.8K (-9.9%) | 142.75M -6.8M (-4.5%) | 0.37% -0.041 pp | 3.20% -0.163 pp | USD103.27 +31.8% | 45 qtrs — |
| 40 | CCLA INVESTMENT MANAGEMENT | 1.05M +19.5K (+1.9%) | 142.54M +10.6M (+8.1%) | 0.37% +0.007 pp | 2.29% +0.177 pp | USD122.50 +11.1% | 14 qtrs — |
| 41 | MACKENZIE FINANCIAL CORP | 1.02M +84.6K (+9.0%) | 140.55M +20.1M (+16.7%) | 0.36% +0.030 pp | 0.17% +0.021 pp | USD125.40 +8.5% | 29 qtrs — |
| 42 | AMUNDI | 1.01M -12.3K (-1.2%) | 137.24M -7.3M (-5.1%) | 0.36% -0.004 pp | 0.04% -0.009 pp | USD139.73 -2.6% | 19 qtrs — |
| 43 | ALLIANCEBERNSTEIN L.P. | 969.6K +154.3K (+18.9%) | 131.94M +27.3M (+26.1%) | 0.34% +0.055 pp | 0.04% +0.009 pp | USD109.43 +24.3% | 61 qtrs — |
| 44 | JANE STREET GROUP, LLC | 924.7K +868.6K (+1,548.8%) | 125.82M +118.6M (+1,648.0%) | 0.33% +0.307 pp | 0.02% +0.018 pp | USD135.95 +0.1% | 48 qtrs — |
| 45 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 919.4K +494.0K (+116.1%) | 125.10M +70.5M (+129.1%) | 0.32% +0.175 pp | 0.07% +0.039 pp | USD131.29 +3.6% | 21 qtrs — |
| 46 | CANDRIAM S.C.A. | 913.1K +30.9K (+3.5%) | 124.25M +11.0M (+9.7%) | 0.32% +0.011 pp | 0.62% +0.026 pp | USD126.49 +7.6% | 45 qtrs — |
| 47 | BESSEMER GROUP INC | 908.3K +23.1K (+2.6%) | 123.59M +10.0M (+8.8%) | 0.32% +0.008 pp | 0.19% +0.016 pp | USD103.13 +31.9% | 39 qtrs — |
| 48 | UBS GROUP AG | 895.3K +90.2K (+11.2%) | 121.82M +18.5M (+17.9%) | 0.32% +0.032 pp | 0.02% +0.004 pp | USD129.09 +5.4% | 45 qtrs — |
| 49 | ROYAL BANK OF CANADA | 886.7K +111.2K (+14.3%) | 120.65M +21.1M (+21.2%) | 0.31% +0.039 pp | 0.02% +0.003 pp | USD129.38 +5.2% | 51 qtrs — |
| 50 | ILEX CAPITAL PARTNERS (UK) LLP | 882.5K +249.8K (+39.5%) | 120.09M +38.9M (+47.9%) | 0.31% +0.088 pp | 3.39% +0.796 pp | USD123.12 +10.5% | 6 qtrs — |
| 51 | BNP PARIBAS ARBITRAGE, SNC | 844.1K +337.2K (+66.5%) | 114.85M +49.8M (+76.5%) | 0.30% +0.119 pp | 0.05% +0.017 pp | USD130.42 +4.3% | 51 qtrs — |
| 52 | MILLENNIUM MANAGEMENT LLC | 838.5K -682.3K (-44.9%) | 114.09M -81.1M (-41.6%) | 0.30% -0.241 pp | 0.05% -0.035 pp | USD131.67 +3.3% | 75 qtrs — |
| 53 | M&G PLC | 820.9K -90.8K (-10.0%) | 111.64M -5.1M (-4.3%) | 0.29% -0.032 pp | 0.57% -0.047 pp | USD125.82 +8.1% | 8 qtrs — |
| 54 | CHAMPLAIN INVESTMENT PARTNERS, LLC | 808.3K -87.5K (-9.8%) | 109.98M -5.0M (-4.3%) | 0.29% -0.031 pp | 1.11% +0.247 pp | USD134.47 +1.2% | 8 qtrs — |
| 55 | SG AMERICAS SECURITIES, LLC | 808.2K +782.9K (+3,091.1%) | 109.97M +106.7M (+3,282.8%) | 0.29% +0.277 pp | 0.14% +0.130 pp | USD135.91 +0.1% | 51 qtrs — |
| 56 | FINDLAY PARK PARTNERS LLP | 804.8K -745.8K (-48.1%) | 109.50M -89.5M (-45.0%) | 0.28% -0.264 pp | 1.40% -0.693 pp | USD119.64 +13.7% | 10 qtrs — |
| 57 | MAN GROUP PLC | 787.4K +276.7K (+54.2%) | 107.14M +41.6M (+63.5%) | 0.28% +0.098 pp | 0.18% +0.068 pp | USD131.49 +3.5% | 32 qtrs — |
| 58 | LGT CAPITAL PARTNERS LTD. | 786.6K -9.5K (-1.2%) | 107.03M +4.9M (+4.8%) | 0.28% -0.003 pp | 5.31% +0.351 pp | USD112.33 +21.1% | 27 qtrs — |
| 59 | NUVEEN, LLC | 786.6K -73.9K (-8.6%) | 107.03M -3.4M (-3.1%) | 0.28% -0.026 pp | 0.03% -0.001 pp | USD117.76 +15.5% | 4 qtrs — |
| 60 | BARCLAYS PLC | 780.8K +27.0K (+3.6%) | 106.24M -5.7M (-5.1%) | 0.28% +0.011 pp | 0.03% -0.003 pp | USD128.31 +6.0% | 51 qtrs — |
| 61 | SWISS NATIONAL BANK | 776.7K -42.1K (-5.1%) | 105.69M +592.6K (+0.6%) | 0.27% -0.015 pp | 0.06% +0.002 pp | USD68.16 +99.6% | 51 qtrs — |
| 62 | LAZARD ASSET MANAGEMENT LLC | 772.4K +71.6K (+10.2%) | 105.09M +15.2M (+16.9%) | 0.27% +0.025 pp | 0.18% +0.057 pp | USD119.86 +13.5% | 41 qtrs — |
| 63 | HSBC HOLDINGS PLC | 753.7K +16.6K (+2.3%) | 102.64M +8.1M (+8.6%) | 0.27% +0.006 pp | 0.05% +0.000 pp | USD118.82 +14.5% | 56 qtrs — |
| 64 | LIONTRUST INVESTMENT PARTNERS LLP | 705.8K -63.0K (-8.2%) | 96.04M -2.6M (-2.7%) | 0.25% -0.022 pp | 1.43% +0.038 pp | USD120.23 +13.2% | 14 qtrs — |
| 65 | FIRST TRUST ADVISORS LP | 696.0K +29.3K (+4.4%) | 94.70M +9.1M (+10.7%) | 0.25% +0.010 pp | 0.07% +0.005 pp | USD128.30 +6.1% | 51 qtrs — |
| 66 | ALLIANZ ASSET MANAGEMENT GMBH | 676.0K -77.4K (-10.3%) | 91.99M -4.7M (-4.9%) | 0.24% -0.027 pp | 0.09% -0.015 pp | USD115.00 +18.3% | 51 qtrs — |
| 67 | ENVESTNET ASSET MANAGEMENT INC | 655.2K +47.3K (+7.8%) | 89.16M +11.1M (+14.3%) | 0.23% +0.017 pp | 0.03% +0.004 pp | USD125.17 +8.7% | 51 qtrs — |
| 68 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 636.7K -32.8K (-4.9%) | 86.64M +704.1K (+0.8%) | 0.23% -0.012 pp | 0.05% +0.001 pp | USD84.67 +60.7% | 59 qtrs — |
| 69 | SUMMITRY LLC | 623.5K +45.0 (+0.0%) | 84.84M +4.8M (+6.0%) | 0.22% +0.000 pp | 3.54% +0.154 pp | USD105.41 +29.1% | 24 qtrs — |
| 70 | MADISON ASSET MANAGEMENT, LLC | 609.4K -44.4K (-6.8%) | 82.92M -994.2K (-1.2%) | 0.22% -0.016 pp | 0.95% +0.028 pp | USD125.40 +8.5% | 10 qtrs — |
| 71 | MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 599.6K +24.7K (+4.3%) | 82.71M +8.9M (+12.1%) | 0.21% +0.009 pp | 0.06% +0.003 pp | USD122.40 +11.2% | 58 qtrs — |
| 72 | JENNISON ASSOCIATES LLC | 606.3K +279.8K (+85.7%) | 82.50M +40.6M (+96.8%) | 0.21% +0.099 pp | 0.05% +0.025 pp | USD138.68 -1.9% | 8 qtrs — |
| 73 | RUSSELL INVESTMENTS GROUP, LTD. | 597.1K +10.5K (+1.8%) | 81.31M +6.1M (+8.1%) | 0.21% +0.004 pp | 0.09% +0.003 pp | USD123.44 +10.2% | 37 qtrs — |
| 74 | FENIMORE ASSET MANAGEMENT INC | 595.0K +8.5K (+1.4%) | 80.96M +5.7M (+7.5%) | 0.21% +0.003 pp | 1.69% +0.177 pp | USD131.59 +3.4% | 9 qtrs — |
| 75 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 583.9K -5.7K (-1.0%) | 79.46M +3.8M (+5.0%) | 0.21% -0.002 pp | 0.05% +0.000 pp | USD81.95 +66.0% | 53 qtrs — |
| 76 | PARNASSUS INVESTMENTS, LLC | 580.9K +120.5K (+26.2%) | 79.05M +19.9M (+33.8%) | 0.21% +0.043 pp | 0.21% +0.068 pp | USD102.75 +32.4% | 26 qtrs — |
| 77 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 577.1K -54.3K (-8.6%) | 78.67M -2.4M (-2.9%) | 0.20% -0.019 pp | 0.13% -0.007 pp | USD126.80 +7.3% | 5 qtrs — |
| 78 | CITADEL ADVISORS LLC | 558.7K +166.0K (+42.3%) | 76.02M +25.6M (+50.8%) | 0.20% +0.059 pp | 0.01% +0.004 pp | USD127.56 +6.7% | 52 qtrs — |
| 79 | SCHARF INVESTMENTS, LLC | 531.2K -36.6K (-6.4%) | 72.29M -595.7K (-0.8%) | 0.19% -0.013 pp | 1.94% +0.110 pp | USD128.35 +6.0% | 2 qtrs — |
| 80 | RHUMBLINE ADVISERS | 514.5K -12.8K (-2.4%) | 70.01M +2.3M (+3.4%) | 0.18% -0.005 pp | 0.06% +0.002 pp | USD65.70 +107.1% | 51 qtrs — |
| 81 | MARSHALL WACE, LLP | 506.2K -1.1M (-68.2%) | 68.88M -135.4M (-66.3%) | 0.18% -0.384 pp | 0.06% -0.145 pp | USD125.74 +8.2% | 16 qtrs — |
| 82 | JUPITER ASSET MANAGEMENT LTD | 499.1K +340.0 (+0.1%) | 67.91M +3.9M (+6.1%) | 0.18% +0.000 pp | 0.54% -0.006 pp | USD132.64 +2.6% | 31 qtrs — |
| 83 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 480.8K +20.8K (+4.5%) | 65.44M +6.4M (+10.8%) | 0.17% +0.007 pp | 0.08% -0.078 pp | USD120.48 +12.9% | 51 qtrs — |
| 84 | EARNEST PARTNERS LLC | 474.6K -1.4K (-0.3%) | 64.57M +3.5M (+5.7%) | 0.17% -0.001 pp | 0.28% +0.012 pp | USD91.65 +48.5% | 51 qtrs — |
| 85 | STEADFAST CAPITAL MANAGEMENT LP | 452.3K +60.3K (+15.4%) | 61.55M +11.2M (+22.3%) | 0.16% +0.021 pp | 1.06% +0.178 pp | USD129.38 +5.2% | 2 qtrs — |
| 86 | RAYMOND JAMES FINANCIAL INC | 451.6K +16.1K (+3.7%) | 61.45M +5.6M (+9.9%) | 0.16% +0.006 pp | 0.02% +0.001 pp | USD132.81 +2.5% | 5 qtrs — |
| 87 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 447.5K -21.0K (-4.5%) | 60.89M +756.8K (+1.3%) | 0.16% -0.007 pp | 0.06% -0.001 pp | USD44.87 +203.3% | 55 qtrs — |
| 88 | NATIONAL PENSION SERVICE | 438.2K -569.0 (-0.1%) | 59.63M +3.3M (+5.9%) | 0.15% 0.000 pp | 0.04% +0.000 pp | USD88.91 +53.0% | 46 qtrs — |
| 89 | PRICE T ROWE ASSOCIATES INC /MD/ | 433.5K -11.9K (-2.7%) | 58.99M +1.8M (+3.2%) | 0.15% -0.004 pp | 0.01% +0.000 pp | USD78.87 +72.5% | 75 qtrs — |
| 90 | WELLS FARGO & COMPANY/MN | 422.6K -19.7K (-4.5%) | 57.51M +732.5K (+1.3%) | 0.15% -0.007 pp | 0.01% 0.000 pp | USD97.03 +40.2% | 57 qtrs — |
| 91 | NORTHWEST & ETHICAL INVESTMENTS L.P. | 417.5K -30.3K (-6.8%) | 56.81M -660.0K (-1.1%) | 0.15% -0.011 pp | 1.28% -0.078 pp | USD107.86 +26.2% | 40 qtrs — |
| 92 | HARVEST PORTFOLIOS GROUP INC. | 407.8K -84.8K (-17.2%) | 55.49M -7.7M (-12.2%) | 0.14% -0.030 pp | 0.96% -0.201 pp | USD133.86 +1.7% | 9 qtrs — |
| 93 | WALLEYE CAPITAL LLC | 403.9K +252.5K (+166.7%) | 54.96M +35.5M (+182.8%) | 0.14% +0.089 pp | 0.17% +0.096 pp | USD133.17 +2.2% | 11 qtrs — |
| 94 | SCHONFELD STRATEGIC ADVISORS LLC | 396.1K +386.3K (+3,940.2%) | 53.90M +52.6M (+4,183.2%) | 0.14% +0.137 pp | 0.24% +0.232 pp | USD135.96 +0.1% | 10 qtrs — |
| 95 | QUANTINNO CAPITAL MANAGEMENT LP | 382.2K +131.8K (+52.6%) | 52.01M +19.9M (+61.8%) | 0.14% +0.047 pp | 0.10% +0.017 pp | USD130.93 +3.9% | 17 qtrs — |
| 96 | PANAGORA ASSET MANAGEMENT INC | 380.5K +110.7K (+41.0%) | 51.77M +17.1M (+49.5%) | 0.13% +0.039 pp | 0.18% +0.044 pp | USD134.89 +0.9% | 67 qtrs — |
| 97 | WORLDQUANT MILLENNIUM ADVISORS LLC | 366.5K +173.1K (+89.5%) | 49.87M +25.1M (+100.9%) | 0.13% +0.061 pp | 0.19% +0.086 pp | USD140.85 -3.4% | 13 qtrs — |
| 98 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 365.4K -300.0 (-0.1%) | 49.72M +2.8M (+5.9%) | 0.13% 0.000 pp | 0.01% +0.000 pp | USD122.14 +11.4% | 51 qtrs — |
| 99 | DANSKE BANK A/S | 356.8K -44.6K (-11.1%) | 48.56M -3.0M (-5.8%) | 0.13% -0.016 pp | 0.11% -0.015 pp | USD131.10 +3.8% | 8 qtrs — |
| 100 | PRINCIPAL FINANCIAL GROUP INC | 339.9K +6.1K (+1.8%) | 46.24M +3.4M (+8.0%) | 0.12% +0.002 pp | 0.02% +0.002 pp | USD118.51 +14.8% | 81 qtrs — |
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | Buckner Michael Steven | Officer | A-Award | A | Common Stock | 8,872 | 0.00 | — | 8,887 | D | ↗ |
| 2026-05-08 | MAY SIMON | Officer | F-InKind | D | Common Stock | 368 | 115.62 | 42.5K | 14,015 | D | ↗ |
| 2026-05-04 | Buckner Michael Steven | Officer | — | — | Common Stock | 0 | 0.00 | — | 15 | D | ↗ |
| 2026-03-31 | Henson Meghan | Officer | F-InKind | D | Common Stock | 153 | 113.98 | 17.4K | 6,890 | D | ↗ |
| 2026-03-19 | WILSON DOW R | Director | A-Award | A | Common Stock | 2,158 | 111.75 | 241.2K | 20,369 | D | ↗ |
| 2026-03-19 | Soriot Pascal | Director | F-InKind | D | Common Stock | 648 | 111.75 | 72.4K | 2,683 | D | ↗ |
| 2026-03-19 | SCANGOS GEORGE A | Director | A-Award | A | Common Stock | 2,158 | 111.75 | 241.2K | 22,800 | D | ↗ |
| 2026-03-19 | Rataj Sue H. | Director | A-Award | A | Common Stock | 2,158 | 111.75 | 241.2K | 23,617 | D | ↗ |
| 2026-03-19 | Podolsky Daniel K | Director | A-Award | A | Common Stock | 2,158 | 111.75 | 241.2K | 38,180 | D | ↗ |
| 2026-03-19 | KOH BOON HWEE | Director | F-InKind | D | Common Stock | 648 | 111.75 | 72.4K | 63,184 | D | ↗ |
| 2026-03-19 | Dolsten Mikael | Director | A-Award | A | Common Stock | 2,158 | 111.75 | 241.2K | 7,138 | D | ↗ |
| 2026-03-19 | Brown Judy L | Director | A-Award | A | Common Stock | 2,158 | 111.75 | 241.2K | 3,835 | D | ↗ |
| 2026-03-19 | BRAWLEY OTIS W | Director | A-Award | A | Common Stock | 2,158 | 111.75 | 241.2K | 12,986 | D | ↗ |
| 2026-03-19 | Anand Mala | Director | A-Award | A | Common Stock | 2,158 | 111.75 | 241.2K | 16,705 | D | ↗ |
| 2026-02-27 | RIEMANN ANGELICA | Officer | F-InKind | D | Common Stock | 89 | 121.38 | 10.8K | 26,535 | D | ↗ |
| 2026-02-27 | MCDONNELL PADRAIG | Director / Officer | F-InKind | D | Common Stock | 279 | 121.38 | 33.9K | 66,260 | D | ↗ |
| 2026-02-27 | KIRKWOOD JONAH PREVOST | Officer | F-InKind | D | Common Stock | 124 | 121.38 | 15.1K | 14,138 | D | ↗ |
| 2025-12-01 | Dolsten Mikael | Director | S-Sale | D | Common Stock | 2,600 | 149.81 | 389.5K | 4,973 | D | ↗ |
| 2025-11-26 | ZHANG JIANMIAO MIKE | Officer | F-InKind | D | Common Stock | 208 | 154.37 | 32.1K | 11,639 | D | ↗ |
| 2025-11-26 | RIEMANN ANGELICA | Officer | F-InKind | D | Common Stock | 280 | 154.37 | 43.2K | 26,594 | D | ↗ |
| 2025-11-26 | MCDONNELL PADRAIG | Director / Officer | F-InKind | D | Common Stock | 1,948 | 154.37 | 300.7K | 66,539 | D | ↗ |
| 2025-11-26 | MAY SIMON | Officer | F-InKind | D | Common Stock | 300 | 154.37 | 46.3K | 14,207 | D | ↗ |
| 2025-11-26 | KIRKWOOD JONAH PREVOST | Officer | F-InKind | D | Common Stock | 430 | 154.37 | 66.4K | 14,262 | D | ↗ |
| 2025-11-26 | Gonsalves Rodney | Officer | S-Sale | D | Common Stock | 3,000 | 154.99 | 465.0K | 31,846 | D | ↗ |
| 2025-11-26 | DiMarco Bret | Officer | F-InKind | D | Common Stock | 332 | 154.37 | 51.3K | 12,203 | D | ↗ |
| 2025-11-21 | ZHANG JIANMIAO MIKE | Officer | F-InKind | D | Common Stock | 67 | 151.25 | 10.1K | 11,847 | D | ↗ |
| 2025-11-21 | RIEMANN ANGELICA | Officer | F-InKind | D | Common Stock | 75 | 151.25 | 11.3K | 26,874 | D | ↗ |
| 2025-11-21 | MCDONNELL PADRAIG | Director / Officer | F-InKind | D | Common Stock | 541 | 151.25 | 81.8K | 68,487 | D | ↗ |
| 2025-11-21 | KIRKWOOD JONAH PREVOST | Officer | F-InKind | D | Common Stock | 113 | 151.25 | 17.1K | 14,692 | D | ↗ |
| 2025-11-21 | Gonsalves Rodney | Officer | F-InKind | D | Common Stock | 138 | 151.25 | 20.9K | 34,846 | D | ↗ |
| 2025-11-18 | ZHANG JIANMIAO MIKE | Officer | F-InKind | D | Common Stock | 452 | 143.84 | 65.0K | 6,687 | D | ↗ |
| 2025-11-18 | RIEMANN ANGELICA | Officer | F-InKind | D | Common Stock | 489 | 143.84 | 70.3K | 20,168 | D | ↗ |
| 2025-11-18 | MCDONNELL PADRAIG | Director / Officer | S-Sale | D | Common Stock | 911 | 143.24 | 130.5K | 32,058 | D | ↗ |
| 2025-11-18 | MAY SIMON | Officer | A-Award | A | Common Stock | 6,781 | 0.00 | — | 14,507 | D | ↗ |
| 2025-11-18 | KIRKWOOD JONAH PREVOST | Officer | A-Award | A | Common Stock | 1,438 | 0.00 | — | 9,502 | D | ↗ |
| 2025-11-18 | Henson Meghan | Officer | A-Award | A | Common Stock | 5,368 | 0.00 | — | 7,043 | D | ↗ |
| 2025-11-18 | Gonsalves Rodney | Officer | F-InKind | D | Common Stock | 883 | 143.84 | 127.0K | 32,582 | D | ↗ |
| 2025-11-18 | Elinoff Adam Stewart | Officer | — | — | Common Stock | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-11-18 | DiMarco Bret | Officer | A-Award | A | Common Stock | 6,922 | 0.00 | — | 12,535 | D | ↗ |
| 2025-11-14 | ZHANG JIANMIAO MIKE | Officer | F-InKind | D | Common Stock | 51 | 146.82 | 7.5K | 5,718 | D | ↗ |
| 2025-11-14 | RIEMANN ANGELICA | Officer | F-InKind | D | Common Stock | 56 | 146.82 | 8.2K | 19,164 | D | ↗ |
| 2025-11-14 | MCDONNELL PADRAIG | Director / Officer | F-InKind | D | Common Stock | 203 | 146.82 | 29.8K | 33,245 | D | ↗ |
| 2025-11-14 | KIRKWOOD JONAH PREVOST | Officer | F-InKind | D | Common Stock | 58 | 146.82 | 8.5K | 8,064 | D | ↗ |
| 2025-11-14 | Gonsalves Rodney | Officer | F-InKind | D | Common Stock | 77 | 146.82 | 11.3K | 31,024 | D | ↗ |
| 2025-11-12 | MCDONNELL PADRAIG | Director / Officer | M-Exempt | A | Common Stock | 12,490 | 109.86 | 1.37M | 45,938 | D | ↗ |
| 2025-09-02 | MCDONNELL PADRAIG | Director / Officer | S-Sale | D | Common Stock | 2,000 | 124.88 | 249.8K | 33,448 | D | ↗ |
| 2025-08-01 | MCDONNELL PADRAIG | Director / Officer | S-Sale | D | Common Stock | 2,000 | 113.45 | 226.9K | 35,448 | D | ↗ |
| 2025-07-16 | Gonsalves Rodney | Officer | A-Award | A | Common Stock | 9,031 | 113.43 | 1.02M | 30,972 | D | ↗ |
| 2025-07-02 | DiMarco Bret | Officer | F-InKind | D | Common Stock | 141 | 120.66 | 17.0K | 5,475 | D | ↗ |
| 2025-07-01 | MCDONNELL PADRAIG | Director / Officer | S-Sale | D | Common Stock | 1,508 | 117.44 | 177.1K | 37,448 | D | ↗ |
| 2025-06-27 | KIRKWOOD JONAH PREVOST | Officer | F-InKind | D | Common Stock | 30 | 119.17 | 3.6K | 8,159 | D | ↗ |
| 2025-06-18 | Brown Judy L | Director | S-Sale | D | Common Stock | 8 | 116.53 | 904.30 | 1,677 | D | ↗ |
| 2025-06-03 | MCDONNELL PADRAIG | Director / Officer | F-InKind | D | Common Stock | 418 | 112.76 | 47.1K | 38,956 | D | ↗ |
| 2025-05-30 | Ancher-Jensen Henrik | Officer | F-InKind | D | Common Stock | 1,755 | 111.92 | 196.4K | 86,426 | D | ↗ |
| 2025-05-22 | McMahon Robert W. | Officer | F-InKind | D | Common Stock | 3,499 | 109.68 | 383.8K | 168,754 | D | ↗ |
| 2025-05-21 | Soriot Pascal | Director | F-InKind | D | Common Stock | 504 | 108.91 | 54.9K | 1,173 | D | ↗ |
| 2025-05-21 | Brown Judy L | Director | A-Award | A | Common Stock | 1,677 | 108.91 | 182.6K | 1,685 | D | ↗ |
| 2025-05-20 | Soriot Pascal | Director | — | — | Common Stock | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-05-20 | Brown Judy L | Director | — | — | Common Stock | 0 | 0.00 | — | 8 | D | ↗ |
| 2025-05-08 | MAY SIMON | Officer | F-InKind | D | Common Stock | 368 | 108.70 | 40.0K | 7,491 | D | ↗ |
| 2025-05-02 | Ancher-Jensen Henrik | Officer | F-InKind | D | Common Stock | 132 | 108.63 | 14.3K | 88,181 | D | ↗ |
| 2025-03-31 | Podolsky Daniel K | Director | S-Sale | D | Common Stock | 1,819 | 116.46 | 211.8K | 35,737 | D | ↗ |
| 2025-03-17 | Gonsalves Rodney | Officer | S-Sale | D | Common Stock | 1,908 | 121.98 | 232.7K | 21,786 | D | ↗ |
| 2025-03-14 | WILSON DOW R | Director | A-Award | A | Common Stock | 1,819 | 121.18 | 220.4K | 18,066 | D | ↗ |
| 2025-03-14 | SCANGOS GEORGE A | Director | A-Award | A | Common Stock | 1,819 | 121.18 | 220.4K | 20,493 | D | ↗ |
| 2025-03-14 | Rataj Sue H. | Director | A-Award | A | Common Stock | 1,819 | 121.18 | 220.4K | 21,459 | D | ↗ |
| 2025-03-14 | Podolsky Daniel K | Director | A-Award | A | Common Stock | 1,819 | 121.18 | 220.4K | 37,556 | D | ↗ |
| 2025-03-14 | KOH BOON HWEE | Director | F-InKind | D | Common Stock | 546 | 121.18 | 66.2K | 61,568 | D | ↗ |
| 2025-03-14 | FIELDS HEIDI | Director | A-Award | A | Common Stock | 1,819 | 121.18 | 220.4K | 58,851 | I | ↗ |
| 2025-03-14 | Dolsten Mikael | Director | A-Award | A | Common Stock | 1,819 | 121.18 | 220.4K | 7,550 | D | ↗ |
| 2025-03-14 | BRAWLEY OTIS W | Director | A-Award | A | Common Stock | 1,819 | 121.18 | 220.4K | 9,930 | D | ↗ |
| 2025-03-14 | Anand Mala | Director | A-Award | A | Common Stock | 1,819 | 121.18 | 220.4K | 14,547 | D | ↗ |
| 2025-03-06 | Rataj Sue H. | Director | S-Sale | D | Common Stock | 6,971 | 126.38 | 881.0K | 19,640 | D | ↗ |
| 2025-03-05 | McMahon Robert W. | Officer | A-Award | A | Common Stock | 5,385 | 126.51 | 681.3K | 172,191 | D | ↗ |
| 2025-03-01 | KIRKWOOD JONAH PREVOST | Officer | — | — | Employee Stock Option (Right to Buy) | 2,609 | 139.06 | 362.8K | 0 | D | ↗ |
| 2025-02-28 | RIEMANN ANGELICA | Officer | F-InKind | D | Common Stock | 84 | 127.92 | 10.7K | 18,993 | D | ↗ |
| 2025-02-28 | MCDONNELL PADRAIG | Director / Officer | F-InKind | D | Common Stock | 278 | 127.92 | 35.6K | 39,374 | D | ↗ |
| 2025-02-28 | KIRKWOOD JONAH PREVOST | Officer | F-InKind | D | Common Stock | 124 | 127.92 | 15.9K | 8,189 | D | ↗ |
| 2025-01-28 | Gonsalves Rodney | Officer | G-Gift | D | Common Stock | 7,149 | 150.34 | 1.07M | 40 | I | ↗ |
| 2025-01-21 | MCDONNELL PADRAIG | Director / Officer | S-Sale | D | Common Stock | 1,911 | 150.00 | 286.7K | 39,652 | D | ↗ |
| 2024-11-29 | Ancher-Jensen Henrik | Officer | F-InKind | D | Common Stock | 2,577 | 137.97 | 355.5K | 88,097 | D | ↗ |
| 2024-11-27 | ZHANG JIANMIAO MIKE | Officer | A-Award | A | Common Stock | 2,569 | 138.14 | 354.9K | 5,796 | D | ↗ |
| 2024-11-27 | RIEMANN ANGELICA | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 9,272 | 138.14 | 1.28M | 9,272 | D | ↗ |
| 2024-11-27 | McMahon Robert W. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 18,544 | 138.14 | 2.56M | 18,544 | D | ↗ |
| 2024-11-27 | MCDONNELL PADRAIG | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 45,202 | 138.14 | 6.24M | 45,202 | D | ↗ |
| 2024-11-27 | MAY SIMON | Officer | A-Award | A | Common Stock | 3,452 | 138.14 | 476.9K | 7,687 | D | ↗ |
| 2024-11-27 | KIRKWOOD JONAH PREVOST | Officer | A-Award | A | Common Stock | 3,212 | 138.14 | 443.7K | 8,313 | D | ↗ |
| 2024-11-27 | Gonsalves Rodney | Officer | A-Award | A | Common Stock | 1,365 | 138.14 | 188.6K | 23,671 | D | ↗ |
| 2024-11-27 | DiMarco Bret | Officer | A-Award | A | Common Stock | 3,814 | 138.14 | 526.9K | 5,432 | D | ↗ |
| 2024-11-27 | Ancher-Jensen Henrik | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 12,517 | 138.14 | 1.73M | 12,517 | D | ↗ |
| 2024-11-22 | ZHANG JIANMIAO MIKE | Officer | — | — | Employee Stock Option (Right to Buy) | 2,382 | 123.99 | 295.3K | 0 | D | ↗ |
| 2024-11-22 | RIEMANN ANGELICA | Officer | — | D | Employee Stock Option (Right to Buy) | 2,522 | 123.99 | 312.7K | 0 | — | ↗ |
| 2024-11-22 | McMahon Robert W. | Officer | F-InKind | D | Common Stock | 5,775 | 133.84 | 772.9K | 160,340 | D | ↗ |
| 2024-11-22 | MCDONNELL PADRAIG | Director / Officer | F-InKind | D | Common Stock | 448 | 133.84 | 60.0K | 25,907 | D | ↗ |
| 2024-11-22 | KIRKWOOD JONAH PREVOST | Officer | — | — | Employee Stock Option (Right to Buy) | 2,382 | 123.99 | 295.3K | 0 | D | ↗ |
| 2024-11-22 | Gonsalves Rodney | Officer | F-InKind | D | Common Stock | 138 | 133.84 | 18.5K | 22,306 | D | ↗ |
| 2024-11-22 | Ancher-Jensen Henrik | Officer | F-InKind | D | Common Stock | 581 | 133.84 | 77.8K | 86,338 | D | ↗ |
| 2024-11-20 | ZHANG JIANMIAO MIKE | Officer | — | — | Common Stock | 0 | 0.00 | — | 3,292 | D | ↗ |
| 2024-11-20 | KIRKWOOD JONAH PREVOST | Officer | — | — | Common Stock | 0 | 0.00 | — | 5,214 | D | ↗ |
| 2024-11-19 | RIEMANN ANGELICA | Officer | F-InKind | D | Common Stock | 327 | 125.69 | 41.1K | 15,896 | D | ↗ |
| 2024-11-19 | McMahon Robert W. | Officer | F-InKind | D | Common Stock | 2,196 | 125.69 | 276.0K | 166,115 | D | ↗ |
| 2024-11-19 | MCDONNELL PADRAIG | Director / Officer | A-Award | A | Common Stock | 4,505 | 125.69 | 566.2K | 27,861 | D | ↗ |
| 2024-11-19 | Gonsalves Rodney | Officer | F-InKind | D | Common Stock | 591 | 125.69 | 74.3K | 22,444 | D | ↗ |
| 2024-11-19 | Binns Philip | Officer | A-Award | A | Common Stock | 653 | 125.69 | 82.1K | 10,650 | D | ↗ |
| 2024-11-19 | Ancher-Jensen Henrik | Officer | F-InKind | D | Common Stock | 2,991 | 125.69 | 375.9K | 86,919 | D | ↗ |
| 2024-11-15 | RIEMANN ANGELICA | Officer | F-InKind | D | Common Stock | 172 | 127.07 | 21.9K | 15,178 | D | ↗ |
| 2024-11-15 | McMahon Robert W. | Officer | F-InKind | D | Common Stock | 1,295 | 127.07 | 164.6K | 160,476 | D | ↗ |
| 2024-11-15 | MCDONNELL PADRAIG | Director / Officer | F-InKind | D | Common Stock | 715 | 127.07 | 90.9K | 23,356 | D | ↗ |
| 2024-11-15 | Gonsalves Rodney | Officer | F-InKind | D | Common Stock | 276 | 127.07 | 35.1K | 21,337 | D | ↗ |
| 2024-11-15 | Ancher-Jensen Henrik | Officer | F-InKind | D | Common Stock | 796 | 127.07 | 101.1K | 81,956 | D | ↗ |
| 2024-09-27 | MCDONNELL PADRAIG | Director / Officer | S-Sale | D | Common Stock | 47 | 150.00 | 7.1K | 24,071 | D | ↗ |
| 2024-09-26 | Grau Dominique | Officer | S-Sale | D | Common Stock | 5,010 | 145.00 | 726.5K | 46,762 | I | ↗ |
| 2024-08-22 | MCDONNELL PADRAIG | Director / Officer | S-Sale | D | Common Stock | 1,958 | 145.00 | 283.9K | 24,118 | — | ↗ |
| 2024-07-26 | MCDONNELL PADRAIG | Director / Officer | S-Sale | D | Common Stock | 1,958 | 140.00 | 274.1K | 26,076 | — | ↗ |
| 2024-07-02 | DiMarco Bret | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 4,595 | 125.78 | 578.0K | 4,595 | — | ↗ |
| 2024-07-01 | DiMarco Bret | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-06-27 | KIRKWOOD JONAH PREVOST | Officer | — | — | Employee Stock Option (Right to Buy) | 646 | 117.04 | 75.6K | 0 | D | ↗ |
| 2024-06-18 | MCDONNELL PADRAIG | Director / Officer | S-Sale | D | Common Stock | 1,958 | 135.00 | 264.3K | 28,034 | — | ↗ |
| 2024-06-10 | Grau Dominique | Officer | S-Sale | D | Common Stock | 15,000 | 133.28 | 2.00M | 49,486 | — | ↗ |
| 2024-06-05 | Grau Dominique | Officer | G-Gift | A | Common Stock | 515 | 133.56 | 68.8K | 52,802 | — | ↗ |
| 2024-06-03 | MCDONNELL PADRAIG | Director / Officer | A-Award | A | Common Stock | 4,807 | 131.40 | 631.6K | 29,992 | — | ↗ |
| 2024-05-29 | SCANGOS GEORGE A | Director | G-Gift | A | Common Stock | 3,443 | 145.48 | 500.9K | 17,893 | — | ↗ |
| 2024-05-17 | RIEMANN ANGELICA | Officer | F-InKind | D | Common Stock | 26 | 154.23 | 4.0K | 15,255 | — | ↗ |
| 2024-05-17 | MCDONNELL PADRAIG | Director / Officer | F-InKind | D | Common Stock | 174 | 154.23 | 26.8K | 27,143 | — | ↗ |
| 2024-05-08 | MAY SIMON | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 11,792 | 142.80 | 1.68M | 11,792 | — | ↗ |
| 2024-05-06 | MAY SIMON | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-05-03 | Ancher-Jensen Henrik | Officer | F-InKind | D | Common Stock | 132 | 139.45 | 18.4K | 82,560 | — | ↗ |
| 2024-03-25 | Binns Philip | Officer | S-Sale | D | Common Stock | 2,827 | 147.54 | 417.1K | 9,997 | — | ↗ |
| 2024-03-15 | WILSON DOW R | Director | A-Award | A | Common Stock | 1,678 | 147.48 | 247.5K | 16,136 | — | ↗ |
| 2024-03-15 | SCANGOS GEORGE A | Director | A-Award | A | Common Stock | 1,678 | 147.48 | 247.5K | 21,989 | — | ↗ |
| 2024-03-15 | Rataj Sue H. | Director | A-Award | A | Common Stock | 1,678 | 147.48 | 247.5K | 26,611 | — | ↗ |
| 2024-03-15 | Podolsky Daniel K | Director | A-Award | A | Common Stock | 1,678 | 147.48 | 247.5K | 35,082 | — | ↗ |
| 2024-03-15 | KOH BOON HWEE | Director | F-InKind | D | Common Stock | 504 | 147.48 | 74.3K | 60,204 | — | ↗ |
| 2024-03-15 | FIELDS HEIDI | Director | A-Award | A | Common Stock | 1,678 | 147.48 | 247.5K | 56,654 | — | ↗ |
| 2024-03-15 | Dolsten Mikael | Director | A-Award | A | Common Stock | 1,678 | 147.48 | 247.5K | 5,711 | — | ↗ |
| 2024-03-15 | Bishop Hans Edgar | Director | A-Award | A | Common Stock | 750 | 147.48 | 110.6K | 24,976 | — | ↗ |
| 2024-03-15 | BRAWLEY OTIS W | Director | A-Award | A | Common Stock | 1,678 | 147.48 | 247.5K | 7,305 | — | ↗ |
| 2024-03-15 | Anand Mala | Director | A-Award | A | Common Stock | 1,678 | 147.48 | 247.5K | 12,728 | — | ↗ |
| 2024-03-08 | McMullen Michael R. | Director / Officer | S-Sale | D | Common Stock | 52,297 | 150.00 | 7.84M | 253,909 | — | ↗ |
| 2024-03-07 | Gonsalves Rodney | Officer | S-Sale | D | Common Stock | 4,828 | 149.00 | 719.3K | 21,329 | — | ↗ |
| 2024-03-05 | FIELDS HEIDI | Director | S-Sale | D | Common Stock | 1,658 | 144.34 | 239.3K | 54,976 | — | ↗ |
| 2024-03-01 | RIEMANN ANGELICA | Officer | A-Award | A | Common Stock | 880 | 139.06 | 122.4K | 15,085 | — | ↗ |
| 2024-03-01 | MCDONNELL PADRAIG | Officer | A-Award | A | Common Stock | 3,202 | 139.06 | 445.3K | 27,317 | — | ↗ |
| 2024-02-20 | RIEMANN ANGELICA | Officer | — | D | Common Stock | 0 | 0.00 | — | 14,205 | — | ↗ |
| 2023-12-27 | Binns Philip | Officer | S-Sale | D | Common Stock | 2,880 | 139.78 | 402.6K | 12,824 | — | ↗ |
| 2023-12-18 | Gonsalves Rodney | Officer | S-Sale | D | Common Stock | 1,500 | 137.69 | 206.5K | 26,133 | — | ↗ |
| 2023-12-15 | Ancher-Jensen Henrik | Officer | M-Exempt | D | Employee Stock Option (Right-to-Buy) | 10,304 | 109.86 | 1.13M | 3,435 | — | ↗ |
| 2023-12-13 | McMullen Michael R. | Director / Officer | M-Exempt | A | Common Stock | 2,751 | 42.12 | 115.9K | 308,957 | — | ↗ |
| 2023-12-07 | McMullen Michael R. | Director / Officer | S-Sale | D | Common Stock | 62,467 | 130.00 | 8.12M | 306,206 | — | ↗ |
| 2023-12-01 | Grau Dominique | Officer | A-Award | A | Common Stock | 16,614 | 128.79 | 2.14M | 64,861 | — | ↗ |
| 2023-12-01 | Ancher-Jensen Henrik | Officer | A-Award | A | Common Stock | 16,614 | 128.79 | 2.14M | 97,132 | — | ↗ |
| 2023-11-22 | Tang Michael | Officer | A-Award | A | Common Stock | 4,150 | 123.99 | 514.6K | 54,872 | — | ↗ |
| 2023-11-22 | McMullen Michael R. | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 71,449 | 123.99 | 8.86M | 71,449 | — | ↗ |
| 2023-11-22 | McMahon Robert W. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 20,734 | 123.99 | 2.57M | 20,734 | — | ↗ |
| 2023-11-22 | MCDONNELL PADRAIG | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 12,328 | 123.99 | 1.53M | 12,328 | — | ↗ |
| 2023-11-22 | Grau Dominique | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 11,488 | 123.99 | 1.42M | 11,488 | — | ↗ |
| 2023-11-22 | Gonsalves Rodney | Officer | A-Award | A | Common Stock | 1,581 | 123.99 | 196.0K | 27,633 | — | ↗ |
| 2023-11-22 | Binns Philip | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 10,087 | 123.99 | 1.25M | 10,087 | — | ↗ |
| 2023-11-22 | Ancher-Jensen Henrik | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 14,010 | 123.99 | 1.74M | 14,010 | — | ↗ |
| 2023-11-17 | Tang Michael | Officer | F-InKind | D | Common Stock | 1,446 | 113.15 | 163.6K | 50,722 | — | ↗ |
| 2023-11-17 | Raha Samraat S. | Officer | F-InKind | D | Common Stock | 1,578 | 113.15 | 178.6K | 85,108 | — | ↗ |
| 2023-11-17 | McMullen Michael R. | Director / Officer | F-InKind | D | Common Stock | 10,206 | 113.15 | 1.15M | 281,011 | — | ↗ |
| 2023-11-17 | McMahon Robert W. | Officer | F-InKind | D | Common Stock | 2,429 | 113.15 | 274.8K | 125,038 | — | ↗ |
| 2023-11-17 | MCDONNELL PADRAIG | Officer | F-InKind | D | Common Stock | 587 | 113.15 | 66.4K | 19,768 | — | ↗ |
| 2023-11-17 | Grau Dominique | Officer | F-InKind | D | Common Stock | 1,587 | 113.15 | 179.6K | 44,196 | — | ↗ |
| 2023-11-17 | Gonsalves Rodney | Officer | F-InKind | D | Common Stock | 356 | 113.15 | 40.3K | 26,052 | — | ↗ |
| 2023-11-17 | Ancher-Jensen Henrik | Officer | F-InKind | D | Common Stock | 1,382 | 113.15 | 156.4K | 75,578 | — | ↗ |
| 2023-11-16 | Tang Michael | Officer | F-InKind | D | Common Stock | 286 | 114.19 | 32.7K | 52,168 | — | ↗ |
| 2023-11-16 | Raha Samraat S. | Officer | F-InKind | D | Common Stock | 345 | 114.19 | 39.4K | 86,686 | — | ↗ |
| 2023-11-16 | McMullen Michael R. | Director / Officer | F-InKind | D | Common Stock | 2,013 | 114.19 | 229.9K | 291,217 | — | ↗ |
| 2023-11-16 | McMahon Robert W. | Officer | F-InKind | D | Common Stock | 504 | 114.19 | 57.6K | 127,467 | — | ↗ |
| 2023-11-16 | MCDONNELL PADRAIG | Officer | F-InKind | D | Common Stock | 290 | 114.19 | 33.1K | 20,355 | — | ↗ |
| 2023-11-16 | Grau Dominique | Officer | F-InKind | D | Common Stock | 349 | 114.19 | 39.9K | 45,783 | — | ↗ |
| 2023-11-16 | Gonsalves Rodney | Officer | F-InKind | D | Common Stock | 77 | 114.19 | 8.8K | 26,408 | — | ↗ |
| 2023-11-16 | Ancher-Jensen Henrik | Officer | F-InKind | D | Common Stock | 375 | 114.19 | 42.8K | 76,960 | — | ↗ |
| 2023-11-15 | ZHANG JIANMIAO MIKE | Officer | — | — | Employee Stock Option (Right to Buy) | 1,856 | 148.00 | 274.7K | 0 | D | ↗ |
| 2023-11-15 | Tang Michael | Officer | F-InKind | D | Common Stock | 359 | 113.60 | 40.8K | 52,454 | — | ↗ |
| 2023-11-15 | Raha Samraat S. | Officer | F-InKind | D | Common Stock | 428 | 113.60 | 48.6K | 87,031 | — | ↗ |
| 2023-11-15 | RIEMANN ANGELICA | Officer | — | D | Employee Stock Option (Right to Buy) | 1,949 | 148.00 | 288.5K | 0 | — | ↗ |
| 2023-11-15 | McMullen Michael R. | Director / Officer | F-InKind | D | Common Stock | 2,510 | 113.60 | 285.1K | 293,230 | — | ↗ |
| 2023-11-15 | McMahon Robert W. | Officer | F-InKind | D | Common Stock | 664 | 113.60 | 75.4K | 127,971 | — | ↗ |
| 2023-11-15 | MCDONNELL PADRAIG | Officer | F-InKind | D | Common Stock | 394 | 113.60 | 44.8K | 20,645 | — | ↗ |
| 2023-11-15 | KIRKWOOD JONAH PREVOST | Officer | — | — | Employee Stock Option (Right to Buy) | 1,253 | 148.00 | 185.4K | 0 | D | ↗ |
| 2023-11-15 | Grau Dominique | Officer | F-InKind | D | Common Stock | 369 | 113.60 | 41.9K | 46,132 | — | ↗ |
| 2023-11-15 | Gonsalves Rodney | Officer | F-InKind | D | Common Stock | 98 | 113.60 | 11.1K | 26,485 | — | ↗ |
| 2023-11-15 | Binns Philip | Officer | — | D | Employee Stock Option (Right to Buy) | 1,160 | 148.00 | 171.7K | 0 | — | ↗ |
| 2023-11-15 | Ancher-Jensen Henrik | Officer | F-InKind | D | Common Stock | 406 | 113.60 | 46.1K | 77,335 | — | ↗ |
| 2023-11-14 | Tang Michael | Officer | F-InKind | D | Common Stock | 3,471 | 111.61 | 387.4K | 52,813 | — | ↗ |
| 2023-11-14 | Raha Samraat S. | Officer | A-Award | A | Common Stock | 11,225 | 111.61 | 1.25M | 90,630 | — | ↗ |
| 2023-11-14 | McMullen Michael R. | Director / Officer | F-InKind | D | Common Stock | 31,877 | 111.61 | 3.56M | 295,740 | — | ↗ |
| 2023-11-14 | McMahon Robert W. | Officer | F-InKind | D | Common Stock | 4,248 | 111.61 | 474.1K | 128,635 | — | ↗ |
| 2023-11-14 | MCDONNELL PADRAIG | Officer | A-Award | A | Common Stock | 9,101 | 111.61 | 1.02M | 24,459 | — | ↗ |
| 2023-11-14 | Grau Dominique | Officer | A-Award | A | Common Stock | 9,709 | 111.61 | 1.08M | 49,979 | — | ↗ |
| 2023-11-14 | Gonsalves Rodney | Officer | A-Award | A | Common Stock | 3,490 | 111.61 | 389.5K | 27,791 | — | ↗ |
| 2023-11-14 | Binns Philip | Officer | A-Award | A | Common Stock | 1,396 | 111.61 | 155.8K | 12,147 | — | ↗ |
| 2023-11-14 | Ancher-Jensen Henrik | Officer | A-Award | A | Common Stock | 10,012 | 111.61 | 1.12M | 81,178 | — | ↗ |
| 2023-09-28 | Gonsalves Rodney | Officer | P-Purchase | D | Common Stock | 0 | 0.00 | — | 24,219 | — | ↗ |
| 2023-09-11 | Binns Philip | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 6,261 | 113.10 | 708.1K | 6,261 | — | ↗ |
| 2023-09-05 | Binns Philip | Officer | — | D | Common Stock | 0 | 0.00 | — | 8,548 | — | ↗ |
| 2023-08-23 | Gonsalves Rodney | Officer | S-Sale | D | Common Stock | 3,500 | 118.78 | 415.7K | 24,219 | — | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Padraig McDonnell President; Chief Executive Officer | 1.14M | — | 8.17M | 2.02M | 1.44M | 61.5K | 12.83M | 79.42% | ↗ |
| 2 | 2025 | Robert McMahon Former Senior Vice President; Former Chief Financial Officer | 665.0K | — | 4.00M | 827.8K | — | 44.6K | 5.54M | 87.19% | ↗ |
| 3 | 2025 | Simon May Senior Vice President, Agilent President Life Sciences and Diagnostics Market Group | 635.4K | 500.0K | 1.80M | 445.0K | 472.4K | 17.4K | 3.87M | 58.02% | ↗ |
| 4 | 2025 | Bret DiMarco Senior Vice President, Chief Legal Officer | 679.8K | — | 1.99M | 491.5K | 475.5K | 21.6K | 3.66M | 67.83% | ↗ |
| 5 | 2025 | Angelica Riemann Senior Vice President, Agilent President Agilent Cross-Lab Group | 591.3K | — | 1.68M | 413.9K | 520.5K | 13.0K | 3.21M | 65.01% | ↗ |
| 6 | 2025 | Rodney Gonsalves Vice President; Controller; Interim Chief Financial Officer | 513.6K | — | 1.69M | 175.9K | 291.6K | 26.9K | 2.70M | 69.13% | ↗ |
| 7 | 2024 | Michael R. McMullen Former Chief Executive Officer | 1.21M | — | 11.70M | 2.92M | 713.6K | 90.5K | 16.62M | 87.89% | ↗ |
| 8 | 2024 | Padraig McDonnell Chief Executive Officer | 870.0K | — | 5.98M | 1.50M | 669.3K | 21.3K | 9.05M | 82.75% | ↗ |
| 9 | 2024 | Padraig McDonnell President; Chief Executive Officer | 870.0K | — | 5.98M | 1.50M | 669.3K | 21.3K | 9.05M | 82.75% | ↗ |
| 10 | 2024 | Robert McMahon Former Senior Vice President; Former Chief Financial Officer | 756.7K | — | 6.87M | 845.9K | 324.6K | 84.0K | 8.88M | 86.88% | ↗ |
| 11 | 2024 | Robert McMahon Senior Vice President, Chief Financial Officer | 756.7K | — | 6.87M | 845.9K | 324.6K | 84.0K | 8.88M | 86.88% | ↗ |
| 12 | 2024 | Henrik Ancher-Jensen Senior Vice President, President Order Fulfillment and Supply Chain | 683.9K | — | 4.32M | 571.6K | 292.6K | 14.3K | 5.88M | 83.15% | ↗ |
| 13 | 2024 | Dominique Grau Senior Vice President, Chief Human Resources Officer | 610.5K | — | 3.91M | 468.7K | 175.4K | 41.2K | 5.20M | 84.13% | ↗ |
| 14 | 2024 | Simon May Senior Vice President, Agilent President Life Sciences and Diagnostics Market Group | 276.9K | 500.0K | 2.26M | 564.8K | 92.1K | 13.8K | 3.71M | 76.21% | ↗ |
| 15 | 2024 | Simon May Senior Vice President, President Diagnostics and Genomics Group | 276.9K | 500.0K | 2.26M | 564.8K | 92.1K | 13.8K | 3.71M | 76.21% | ↗ |
| 16 | 2023 | Michael R. McMullen Former Chief Executive Officer | 1.32M | — | 11.33M | 2.78M | 514.6K | 84.0K | 16.02M | 88.05% | ↗ |
| 17 | 2023 | Michael R. McMullen Chief Executive Officer | 1.32M | — | 11.33M | 2.78M | 514.6K | 84.0K | 16.02M | 88.05% | ↗ |
| 18 | 2023 | Robert McMahon Senior Vice President, Chief Financial Officer | 726.8K | — | 3.00M | 735.9K | 259.6K | 89.0K | 4.81M | 77.64% | ↗ |
| 19 | 2023 | Robert McMahon Former Senior Vice President; Former Chief Financial Officer | 726.8K | — | 3.00M | 735.9K | 259.6K | 89.0K | 4.81M | 77.64% | ↗ |
| 20 | 2023 | Henrik Ancher-Jensen Senior Vice President, President Order Fulfillment and Supply Chain | 673.4K | — | 1.93M | 474.2K | 240.0K | 14.0K | 3.33M | 72.18% | ↗ |
| 21 | 2023 | Sam Raha Senior Vice President, President Diagnostics and Genomics Group | 631.2K | — | 1.93M | 474.2K | 204.4K | 41.1K | 3.28M | 73.30% | ↗ |
| 22 | 2023 | Padraig McDonnell Senior Vice President, President Agilent Cross Lab Group | 606.2K | — | 1.78M | 436.1K | 316.4K | 137.1K | 3.27M | 67.62% | ↗ |
| 23 | 2023 | Padraig McDonnell President; Chief Executive Officer | 606.2K | — | 1.78M | 436.1K | 316.4K | 137.1K | 3.27M | 67.62% | ↗ |
| 24 | 2023 | Padraig McDonnell Chief Executive Officer | 606.2K | — | 1.78M | 436.1K | 316.4K | 137.1K | 3.27M | 67.62% | ↗ |
| 25 | 2022 | Michael R. McMullen Former Chief Executive Officer | 1.28M | — | 10.51M | 2.48M | 2.30M | 81.6K | 16.65M | 78.02% | ↗ |
| 26 | 2022 | Michael R. McMullen Chief Executive Officer | 1.28M | — | 10.51M | 2.48M | 2.30M | 81.6K | 16.65M | 78.02% | ↗ |
| 27 | 2022 | Robert McMahon Senior Vice President, Chief Financial Officer | 696.4K | — | 2.63M | 620.9K | 717.7K | 129.3K | 4.79M | 67.78% | ↗ |
| 28 | 2022 | Padraig McDonnell Chief Executive Officer | 571.2K | — | 1.51M | 357.0K | 653.0K | 70.7K | 4.79M | 38.98% | ↗ |
| 29 | 2022 | Henrik Ancher-Jensen Senior Vice President, President Order Fulfillment and Supply Chain | 605.0K | — | 2.57M | 576.2K | 676.7K | 23.6K | 4.46M | 70.71% | ↗ |
| 30 | 2022 | Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group | 647.4K | — | 2.10M | 496.7K | 797.5K | 17.3K | 4.06M | 63.99% | ↗ |
| 31 | 2022 | Sam Raha Senior Vice President, President Diagnostics and Genomics Group | 596.4K | — | 1.79M | 424.3K | 504.4K | 39.3K | 3.36M | 66.06% | ↗ |
| 32 | 2022 | Padraig McDonnell Senior Vice President, President Agilent Cross Lab Group | 571.2K | — | 1.51M | 357.0K | 653.0K | 70.7K | 3.16M | 59.05% | ↗ |
| 33 | 2021 | Michael R. McMullen Chief Executive Officer | 1.28M | — | 9.17M | 2.30M | 3.15M | 77.5K | 15.97M | 71.77% | ↗ |
| 34 | 2021 | Robert McMahon Senior Vice President, Chief Financial Officer | 663.5K | — | 2.29M | 573.8K | 1.01M | 176.2K | 4.71M | 60.81% | ↗ |
| 35 | 2021 | Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group | 625.0K | — | 1.81M | 453.8K | 897.6K | 13.7K | 3.80M | 59.60% | ↗ |
| 36 | 2021 | Sam Raha Senior Vice President, President Diagnostics and Genomics Group | 563.5K | — | 1.54M | 386.0K | 738.5K | 33.5K | 3.26M | 59.07% | ↗ |
| 37 | 2021 | Padraig McDonnell Senior Vice President, President Cross-Lab Group | 495.0K | — | 1.25M | 313.0K | 686.7K | 499.5K | 3.24M | 48.17% | ↗ |
| 38 | 2021 | Padraig McDonnell Senior Vice President, President Agilent Cross Lab Group | 495.0K | — | 1.25M | 313.0K | 686.7K | 499.5K | 3.24M | 48.17% | ↗ |
| 39 | 2020 | Michael R. McMullen Chief Executive Officer | 1.17M | — | 11.19M | — | 1.15M | 95.1K | 13.61M | 82.22% | ↗ |
| 40 | 2020 | Robert McMahon Senior Vice President, Chief Financial Officer | 638.3K | — | 2.61M | — | 359.9K | 52.3K | 3.67M | 71.34% | ↗ |
| 41 | 2020 | Mark Doak Senior Vice President, President Agilent Cross-Lab Group | 316.5K | 500.0K | 2.61M | — | 189.9K | 22.4K | 3.64M | 71.76% | ↗ |
| 42 | 2020 | Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group | 614.9K | — | 2.12M | — | 321.1K | 20.3K | 3.07M | 68.89% | ↗ |
| 43 | 2020 | Sam Raha Senior Vice President, President Diagnostics and Genomics Group | 538.8K | — | 1.67M | — | 224.2K | 34.8K | 2.47M | 67.72% | ↗ |
| 44 | 2020 | Michael Tang Senior Vice President, General Counsel | 561.0K | — | 1.57M | — | 276.2K | 33.8K | 2.44M | 64.30% | ↗ |
| 45 | 2019 | Michael R. McMullen Chief Executive Officer | 1.22M | — | 9.56M | — | 1.58M | 161.9K | 12.52M | 76.36% | ↗ |
| 46 | 2019 | Robert McMahon Senior Vice President, Chief Financial Officer | 610.0K | 1.00M | 2.22M | — | 483.3K | 64.9K | 4.38M | 50.72% | ↗ |
| 47 | 2019 | Mark Doak Senior Vice President, President Agilent Cross-Lab Group | 597.9K | — | 2.24M | — | 550.3K | 40.4K | 3.43M | 65.34% | ↗ |
| 48 | 2019 | Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group | 597.9K | — | 1.86M | — | 346.8K | 93.9K | 2.90M | 64.15% | ↗ |
| 49 | 2019 | Michael Tang Senior Vice President, General Counsel | 545.8K | — | 1.35M | — | 381.3K | 64.4K | 2.34M | 57.69% | ↗ |
| 50 | 2018 | Michael R. McMullen Chief Executive Officer | 1.17M | — | 8.48M | — | 1.86M | 199.8K | 11.71M | 72.39% | ↗ |
| 51 | 2018 | Robert McMahon Senior Vice President, Chief Financial Officer | 147.9K | 2.00M | 4.13M | — | 146.8K | 155.4K | 6.58M | 62.78% | ↗ |
| 52 | 2018 | Didier Hirsch Former Senior Vice President, Chief Financial Officer | 648.3K | — | 2.81M | — | 634.4K | 81.4K | 4.17M | 67.31% | ↗ |
| 53 | 2018 | Mark Doak Senior Vice President, President Cross-Lab Group | 570.8K | — | 2.09M | — | 620.4K | 42.0K | 3.32M | 62.87% | ↗ |
| 54 | 2018 | Mark Doak Senior Vice President, President Agilent Cross-Lab Group | 570.8K | — | 2.09M | — | 620.4K | 42.0K | 3.32M | 62.87% | ↗ |
| 55 | 2018 | Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group | 556.3K | — | 1.85M | — | 484.8K | 129.1K | 3.02M | 61.20% | ↗ |
| 56 | 2018 | Dominique Grau Senior Vice President, Human Resources | 470.6K | — | 1.28M | — | 403.0K | 62.6K | 2.21M | 57.69% | ↗ |
| 57 | 2017 | Michael R. McMullen Chief Executive Officer | 1.10M | — | 7.21M | — | 1.58M | 209.3K | 10.09M | 71.41% | ↗ |
| 58 | 2017 | Didier Hirsch Senior Vice President, Chief Financial Officer | 627.5K | — | 2.68M | — | 556.9K | 79.9K | 3.94M | 67.91% | ↗ |
| 59 | 2017 | Didier Hirsch Former Senior Vice President, Chief Financial Officer | 627.5K | — | 2.68M | — | 556.9K | 79.9K | 3.94M | 67.91% | ↗ |
| 60 | 2017 | Patrick Kaltenbach Senior Vice President, President Life Sciences and Applied Markets Group | 532.1K | — | 1.79M | — | 456.2K | 770.6K | 3.55M | 50.41% | ↗ |
| 61 | 2017 | Mark Doak Senior Vice President, President Cross-Lab Group | 520.8K | — | 1.90M | — | 453.8K | 51.8K | 2.93M | 64.91% | ↗ |
| 62 | 2017 | Mark Doak Senior Vice President, President Agilent Cross-Lab Group | 520.8K | — | 1.90M | — | 453.8K | 51.8K | 2.93M | 64.91% | ↗ |
| 63 | 2017 | Jacob Thaysen Senior Vice President, President Diagnostics and Genomics Group | 495.0K | — | 1.34M | — | 356.6K | 211.2K | 2.40M | 55.73% | ↗ |
| 64 | 2017 | Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group | 495.0K | — | 1.34M | — | 356.6K | 211.2K | 2.40M | 55.73% | ↗ |
| 65 | 2016 | Michael R. McMullen Chief Executive Officer | 1.04M | — | 6.34M | — | 1.34M | 193.3K | 8.91M | 71.13% | ↗ |
| 66 | 2016 | Patrick Kaltenbach Senior Vice President, President Life Sciences and Applied Markets Group | 488.0K | — | 1.48M | — | 418.1K | 2.01M | 4.39M | 33.67% | ↗ |
| 67 | 2016 | Didier Hirsch Senior Vice President, Chief Financial Officer | 600.0K | — | 2.75M | — | 494.1K | 90.5K | 3.93M | 69.88% | ↗ |
| 68 | 2016 | Didier Hirsch Former Senior Vice President, Chief Financial Officer | 600.0K | — | 2.75M | — | 494.1K | 90.5K | 3.93M | 69.88% | ↗ |
| 69 | 2016 | Jacob Thaysen Senior Vice President, President Diagnostics and Genomics Group | 436.7K | — | 845.5K | — | 510.8K | 1.02M | 2.81M | 30.05% | ↗ |
| 70 | 2016 | Jacob Thaysen Senior Vice President, President Life Sciences and Applied Markets Group | 436.7K | — | 845.5K | — | 510.8K | 1.02M | 2.81M | 30.05% | ↗ |
| 71 | 2016 | Mark Doak Senior Vice President, President Cross-Labs Group | 470.8K | — | 1.64M | — | 476.9K | 54.4K | 2.64M | 62.04% | ↗ |
| 72 | 2016 | Mark Doak Senior Vice President, President Cross-Lab Group | 470.8K | — | 1.64M | — | 476.9K | 54.4K | 2.64M | 62.04% | ↗ |
| 73 | 2015 | Michael R. McMullen President Chief Executive Officer | 845.8K | — | 2.52M | 2.43M | 1.11M | 296.3K | 7.21M | 68.74% | ↗ |
| 74 | 2015 | Michael R. McMullen Chief Executive Officer | 845.8K | — | 2.52M | 2.43M | 1.11M | 296.3K | 7.21M | 68.74% | ↗ |
| 75 | 2015 | William P. Sullivan Former President and Chief Executive Officer | 630.0K | — | 3.06M | 1.95M | 894.3K | 28.5K | 6.47M | 77.36% | ↗ |
| 76 | 2015 | Didier Hirsch Senior Vice President, Chief Financial Officer | 600.0K | — | 1.05M | 1.00M | 516.4K | 129.7K | 3.30M | 62.20% | ↗ |
| 77 | 2015 | Patrick Kaltenbach Senior Vice President, President Life Sciences and Applied Markets Group | 407.3K | — | 505.1K | 481.3K | 311.7K | 945.7K | 2.65M | 37.21% | ↗ |
| 78 | 2015 | Henrik Ancher-Jensen Senior Vice President, President Order Fulfillment and Supply Chain | 398.9K | — | 274.7K | 262.3K | 1.17M | 153.0K | 2.26M | 23.73% | ↗ |
| 79 | 2015 | Mark Doak Senior Vice President, President Cross-Lab Group | 422.9K | — | 549.5K | 524.7K | 421.7K | 46.3K | 1.97M | 54.66% | ↗ |
| 80 | 2015 | Mark Doak Senior Vice President, President Cross-Labs Group | 422.9K | — | 549.5K | 524.7K | 421.7K | 46.3K | 1.97M | 54.66% | ↗ |
| 81 | 2014 | William P. Sullivan Chief Executive Officer | 1.05M | — | 6.63M | — | 1.63M | 31.8K | 13.91M | 47.67% | ↗ |
| 82 | 2014 | William P. Sullivan Former President and Chief Executive Officer | 1.05M | — | 6.63M | 4.57M | 1.63M | 31.8K | 13.91M | 80.50% | ↗ |
| 83 | 2014 | Ronald S. Nersesian Executive Vice President and Keysight | 795.8K | — | 2.11M | — | 917.2K | 31.0K | 6.26M | 33.70% | ↗ |
| 84 | 2014 | Michael R. McMullen President and Chief Operating Officer | 606.3K | — | 2.33M | — | 467.2K | 39.1K | 4.53M | 51.48% | ↗ |
| 85 | 2014 | Michael R. McMullen President Chief Executive Officer | 606.3K | — | 2.33M | 994.4K | 467.2K | 130.8K | 4.53M | 73.42% | ↗ |
| 86 | 2014 | Michael R. McMullen Chief Executive Officer | 606.3K | — | 2.33M | 994.4K | 467.2K | 130.8K | 4.53M | 73.42% | ↗ |
| 87 | 2014 | Didier Hirsch Senior Vice President, Chief Financial Officer | 600.0K | — | 1.04M | 1.05M | 633.4K | 127.4K | 3.45M | 60.60% | ↗ |
| 88 | 2014 | Didier Hirsch Senior Vice President, Chief Financial Officer | 600.0K | — | 1.04M | — | 633.4K | 16.3K | 3.45M | 30.25% | ↗ |
| 89 | 2014 | Marie Oh Huber | 525.0K | — | 1.01M | — | 495.0K | 28.9K | 2.91M | 34.67% | ↗ |
| 90 | 2013 | William P. Sullivan Chief Executive Officer | 1.05M | — | 3.79M | — | 1.23M | 30.7K | 10.24M | 37.03% | ↗ |
| 91 | 2013 | William P. Sullivan President and Chief Executive Officer | 1.05M | — | 3.79M | — | 1.23M | 30.7K | 10.24M | 37.03% | ↗ |
| 92 | 2013 | William P. Sullivan Former President and Chief Executive Officer | 1.05M | — | 3.79M | 4.14M | 1.23M | 30.7K | 10.24M | 77.49% | ↗ |
| 93 | 2013 | Ronald S. Nersesian Executive Vice President and Keysight | 741.7K | — | 1.56M | — | 585.2K | 27.9K | 4.76M | 32.79% | ↗ |
| 94 | 2013 | Ronald S. Nersesian Executive Vice President and President and Chief | 741.7K | — | 1.56M | — | 585.2K | 27.9K | 4.76M | 32.79% | ↗ |
| 95 | 2013 | Nicolas Roelofs Former Senior Vice President, Life Sciences | 550.0K | — | 668.8K | — | 452.2K | 1.85M | 4.34M | 15.42% | ↗ |
| 96 | 2013 | Didier Hirsch Senior Vice President, Chief Financial Officer | 597.9K | — | 869.5K | — | 382.2K | 21.7K | 2.93M | 29.65% | ↗ |
| 97 | 2013 | Didier Hirsch Senior Vice President, Chief Financial Officer | 597.9K | — | 869.5K | 950.0K | 382.2K | 132.6K | 2.93M | 62.05% | ↗ |
| 98 | 2013 | Lars Holmkvist | 938.6K | — | 891.7K | — | 776.9K | 286.8K | 2.89M | 30.81% | ↗ |
| 99 | 2013 | Michael R. McMullen Senior Vice President, Chemical Analysis Group | 575.0K | — | 802.6K | — | 465.7K | 30.1K | 2.86M | 28.09% | ↗ |
| 100 | 2013 | Michael R. McMullen President and Chief Operating Officer | 575.0K | — | 802.6K | — | 465.7K | 30.1K | 2.86M | 28.09% | ↗ |
| 101 | 2013 | Michael R. McMullen President Chief Executive Officer | 575.0K | — | 802.6K | 877.0K | 465.7K | 136.6K | 2.86M | 58.79% | ↗ |
| 102 | 2012 | William P. Sullivan President and Chief Executive Officer | 990.0K | — | 3.86M | — | 1.25M | 30.9K | 10.14M | 38.08% | ↗ |
| 103 | 2012 | William P. Sullivan Chief Executive Officer | 990.0K | — | 3.86M | — | 1.25M | 30.9K | 10.14M | 38.08% | ↗ |
| 104 | 2012 | Ronald S. Nersesian Executive Vice President and Chief Operating | 641.7K | — | 1.48M | — | 518.9K | 26.9K | 4.33M | 34.26% | ↗ |
| 105 | 2012 | Ronald S. Nersesian Executive Vice President and President and Chief | 641.7K | — | 1.48M | — | 518.9K | 26.9K | 4.33M | 34.26% | ↗ |
| 106 | 2012 | Ronald S. Nersesian Executive Vice President and Keysight | 641.7K | — | 1.48M | — | 518.9K | 26.9K | 4.33M | 34.26% | ↗ |
| 107 | 2012 | Nicolas Roelofs Former Senior Vice President, Life Sciences | 545.8K | — | 1.72M | — | 413.5K | 209.2K | 3.80M | 45.35% | ↗ |
| 108 | 2012 | Nicolas H. Roelofs Senior Vice President, Life Sciences Group | 545.8K | — | 1.72M | — | 413.5K | 209.2K | 3.80M | 45.35% | ↗ |
| 109 | 2012 | Michael R. McMullen President and Chief Operating Officer | 570.8K | — | 1.77M | — | 443.8K | 31.0K | 3.80M | 46.66% | ↗ |
| 110 | 2012 | Michael R. McMullen Senior Vice President, Chemical Analysis Group | 570.8K | — | 1.77M | — | 443.8K | 31.0K | 3.80M | 46.66% | ↗ |
| 111 | 2012 | Didier Hirsch Senior Vice President, Chief Financial Officer | 570.8K | — | 890.6K | — | 471.2K | 16.0K | 2.98M | 29.89% | ↗ |
| 112 | 2011 | William P. Sullivan President and Chief Executive Officer | 990.0K | — | 3.52M | — | 1.92M | 30.2K | 10.25M | 34.35% | ↗ |
| 113 | 2011 | Ronald S. Nersesian Executive Vice President and Chief Operating | 545.8K | — | 1.76M | — | 740.3K | 26.0K | 4.31M | 40.85% | ↗ |
| 114 | 2011 | Ronald S. Nersesian Executive Vice President and President and Chief | 545.8K | — | 1.76M | — | 740.3K | 26.0K | 4.31M | 40.85% | ↗ |
| 115 | 2011 | Ronald S. Nersesian Executive Vice President and Chief Operating Officer | 545.8K | — | 1.76M | — | 740.3K | 26.0K | 4.31M | 40.85% | ↗ |
| 116 | 2011 | Michael R. McMullen Senior Vice President, Chemical Analysis Group | 519.6K | — | 1.51M | — | 387.5K | 29.6K | 3.41M | 44.28% | ↗ |
| 117 | 2011 | Nicolas Roelofs Former Senior Vice President, Life Sciences | 493.8K | — | 1.41M | — | 394.9K | 10.7K | 3.14M | 44.83% | ↗ |
| 118 | 2011 | Nicolas Roelofs Senior Vice President, Life Sciences Group | 493.8K | — | 1.41M | — | 394.9K | 10.7K | 3.14M | 44.83% | ↗ |
| 119 | 2011 | Nicolas H. Roelofs Senior Vice President, Life Sciences Group | 493.8K | — | 1.41M | — | 394.9K | 10.7K | 3.14M | 44.83% | ↗ |
| 120 | 2011 | Didier Hirsch Senior Vice President, Chief Financial Officer | 520.8K | — | 1.02M | — | 556.8K | 13.6K | 3.02M | 33.75% | ↗ |
| 121 | 2011 | Didier Hirsch Senior Vice President, Chief Financial Officer | 520.8K | — | 1.02M | — | 556.8K | 13.6K | 3.01M | 33.80% | ↗ |
| 122 | 2010 | William P. Sullivan President and Chief Executive Officer | 990.0K | — | 3.40M | — | 2.54M | 29.9K | 10.44M | 32.51% | ↗ |
| 123 | 2010 | Ronald S. Nersesian Executive Vice President and Chief Operating | 497.1K | — | 1.08M | — | 712.5K | 25.2K | 3.51M | 30.60% | ↗ |
| 124 | 2010 | Ronald S. Nersesian Executive Vice President and Chief Operating Officer | 497.1K | — | 1.08M | — | 712.5K | 25.2K | 3.51M | 30.60% | ↗ |
| 125 | 2010 | Ronald S. Nersesian Senior Vice President, Electronic Measurement | 497.1K | — | 1.08M | — | 712.5K | 25.2K | 3.51M | 30.60% | ↗ |
| 126 | 2010 | Adrian Dillon Former Executive Vice President, Finance and | 350.0K | — | 1.19M | — | 446.2K | 18.1K | 3.28M | 36.23% | ↗ |
| 127 | 2010 | Michael R. McMullen Senior Vice President, Chemical Analysis Group | 457.1K | — | 905.3K | — | 557.7K | 40.7K | 2.99M | 30.27% | ↗ |
| 128 | 2010 | Didier Hirsch Senior Vice President, Chief Financial Officer | 366.2K | — | 636.4K | — | 456.4K | 238.9K | 2.42M | 26.26% | ↗ |
| 129 | 2010 | Nicolas Roelofs Senior Vice President, Life Sciences Group | 425.0K | — | 679.0K | — | 446.5K | 11.0K | 2.35M | 28.86% | ↗ |
| 130 | 2010 | Nicolas H. Roelofs Senior Vice President, Life Sciences Group | 425.0K | — | 679.0K | — | 446.5K | 11.0K | 2.35M | 28.86% | ↗ |
| 131 | 2010 | Didier Hirsch Senior Vice President, Chief Financial Officer | 366.2K | — | 636.4K | — | 456.4K | 71.7K | 2.26M | 28.20% | ↗ |
| 132 | 2009 | William P. Sullivan President and Chief Executive Officer | 907.5K | — | 2.72M | — | 949.6K | 28.3K | 7.57M | 35.89% | ↗ |
| 133 | 2009 | Adrian T. Dillon Executive Vice President, Finance and | 641.7K | — | 1.39M | — | 407.7K | 25.4K | 3.74M | 37.25% | ↗ |
| 134 | 2009 | Adrian Dillon Former Executive Vice President, Finance and | 641.7K | — | 1.04M | — | 407.7K | 25.4K | 3.24M | 32.16% | ↗ |
| 135 | 2009 | D. Craig Nordlund Former Senior Vice President, General | 389.6K | — | 362.3K | — | 203.8K | 1.55M | 2.86M | 12.69% | ↗ |
| 136 | 2009 | Ronald S. Nersesian Senior Vice President, Electronic Measurement | 413.1K | — | 931.9K | — | 271.6K | 25.1K | 2.33M | 39.92% | ↗ |
| 137 | 2009 | Ronald S. Nersesian Executive Vice President and Chief Operating Officer | 413.1K | — | 931.9K | — | 271.6K | 25.1K | 2.33M | 39.92% | ↗ |
| 138 | 2009 | Michael R. McMullen Senior Vice President, Chemical Analysis Group | 339.1K | — | 754.4K | — | 254.6K | 107.5K | 2.04M | 36.98% | ↗ |
| 139 | 2009 | Ronald S. Nersesian Senior Vice President, | 413.1K | — | 588.8K | — | 271.6K | 25.1K | 1.77M | 33.21% | ↗ |
| 140 | 2009 | Nicolas Roelofs Senior Vice President, Life Sciences Group | 339.1K | — | 641.2K | — | 250.9K | 22.2K | 1.61M | 39.72% | ↗ |
| 141 | 2009 | Michael R. McMullen Senior Vice President, Chemical Analysis Group | 334.6K | — | 444.0K | 287.8K | 254.6K | 107.5K | 1.60M | 45.75% | ↗ |
| 142 | 2009 | Nicolas Roelofs Senior Vice President, Life Sciences Group | 334.6K | — | 558.0K | 267.3K | 250.9K | 22.2K | 1.49M | 55.42% | ↗ |
| 143 | 2008 | William P. Sullivan President and Chief | 986.7K | — | 3.74M | — | 1.31M | 28.5K | 9.17M | 40.76% | ↗ |
| 144 | 2008 | William P. Sullivan President and Chief Executive Officer | 986.7K | — | 3.74M | — | 1.31M | 28.5K | 9.17M | 40.76% | ↗ |
| 145 | 2008 | Adrian Dillon Former Executive Vice President, Finance and | 700.0K | — | 1.56M | — | 627.8K | 24.1K | 4.17M | 37.47% | ↗ |
| 146 | 2008 | Adrian T. Dillon Executive Vice President, Finance and | 700.0K | — | 1.64M | — | 627.8K | 24.1K | 4.00M | 40.95% | ↗ |
| 147 | 2008 | Adrian T. Dillon Executive Vice President, | 700.0K | — | 1.64M | — | 627.8K | 24.1K | 4.00M | 40.95% | ↗ |
| 148 | 2008 | Jean Halloran Senior Vice President, | 400.0K | — | 631.7K | — | 295.4K | 23.2K | 1.92M | 32.82% | ↗ |
| 149 | 2008 | Ronald S. Nersesian Senior Vice President, Electronic Measurement | 397.9K | — | 679.3K | — | 239.1K | 24.5K | 1.92M | 35.47% | ↗ |
| 150 | 2008 | D. Craig Nordlund Former Senior Vice President, General | 425.0K | — | 543.4K | — | 313.9K | 22.6K | 1.70M | 31.98% | ↗ |
| 151 | 2008 | D. Craig Nordlund Senior Vice President, | 425.0K | — | 543.4K | — | 313.9K | 22.6K | 1.70M | 31.98% | ↗ |
| 152 | 2008 | Ronald S. Nersesian Senior Vice President, Electronic Measurement | 397.9K | — | 469.6K | 267.0K | 239.1K | 24.5K | 1.48M | 49.86% | ↗ |
| 153 | 2008 | Ronald S. Nersesian Senior Vice President, | 397.9K | — | 469.6K | — | 239.1K | 24.5K | 1.48M | 31.78% | ↗ |
| 154 | 2007 | William P. Sullivan President and Chief Executive Officer | 946.9K | 650.00 | 10.26M | 2.74M | 618.8K | 43.4K | 15.01M | 86.58% | ↗ |
| 155 | 2007 | William P. Sullivan President and Chief Executive Officer | 946.9K | 650.00 | 10.26M | — | 618.8K | 43.4K | 15.01M | 68.34% | ↗ |
| 156 | 2007 | William P. Sullivan President and Chief | 946.9K | 650.00 | 10.26M | — | 618.8K | 43.4K | 15.01M | 68.34% | ↗ |
| 157 | 2007 | Patrick J. Byrne Former Senior Vice President and President, Electronics Management Group | 639.9K | — | 3.99M | 2.06M | 208.1K | 1.22M | 8.33M | 72.56% | ↗ |
| 158 | 2007 | Adrian T. Dillon Executive Vice President, Finance and Administration and Chief Financial Officer | 700.0K | 525.1K | 4.15M | 700.1K | 323.0K | 544.4K | 7.07M | 68.68% | ↗ |
| 159 | 2007 | Adrian T. Dillon Executive Vice President, | 700.0K | 525.1K | 4.15M | — | 323.0K | 544.4K | 7.07M | 58.77% | ↗ |
| 160 | 2007 | Adrian T. Dillon Executive Vice President, Finance and | 700.0K | 525.1K | 4.15M | — | 323.0K | 544.4K | 7.07M | 58.77% | ↗ |
| 161 | 2007 | Christopher van Ingen Former Senior Vice President and President, Life Sciences and Chemical Analysis Group | 450.0K | — | 4.18M | 896.2K | 421.2K | 34.6K | 6.11M | 83.01% | ↗ |
| 162 | 2007 | Jean Halloran Senior Vice President, | 400.0K | — | 2.07M | — | 141.1K | 34.9K | 3.38M | 61.34% | ↗ |
| 163 | 2007 | Jean Halloran Senior Vice President, Human Resources | 400.0K | — | 2.07M | 669.8K | 141.1K | 34.9K | 3.38M | 81.15% | ↗ |
| 164 | 2007 | D. Craig Nordlund Senior Vice President, General Counsel and Secretary | 425.0K | 650.00 | 1.73M | 348.3K | 150.0K | 35.4K | 2.69M | 77.34% | ↗ |
| 165 | 2007 | D. Craig Nordlund Senior Vice President, | 425.0K | 650.00 | 1.73M | — | 150.0K | 35.4K | 2.69M | 64.38% | ↗ |
| 166 | 2007 | D. Craig Nordlund Former Senior Vice President, General | 425.0K | 650.00 | 1.73M | — | 150.0K | 35.4K | 2.69M | 64.38% | ↗ |
| 167 | 2006 | William P. Sullivan President and Chief Executive Officer | 906.2K | 1.14M | — | 213.6K | — | 8.8K | 2.06M | 10.39% | ↗ |
| 168 | 2006 | Adrian T. Dillon Executive Vice President, Finance and Administration, Chief Financial Officer | 687.5K | 588.2K | — | 108.0K | — | 8.8K | 1.28M | 8.41% | ↗ |
| 169 | 2006 | Patrick J. Byrne Senior Vice President, Electronics Measurement Group | 472.5K | 373.3K | — | 94.5K | — | 8.8K | 854.6K | 11.06% | ↗ |
| 170 | 2006 | D. Craig Nordlund Senior Vice President, General Counsel and Secretary | 425.0K | 247.6K | — | 33.2K | — | 8.8K | 681.4K | 4.87% | ↗ |
| 171 | 2006 | Christopher van Ingen Senior Vice President, Life Science and Chemical Analysis | 437.5K | 227.8K | — | 85.0K | — | 8.8K | 674.1K | 12.61% | ↗ |
| 172 | 2005 | Edward W. Barnholt Former President and Chief Executive Officer | 1.00M | 1.31M | — | 160.0K | — | 8.4K | 2.32M | 6.89% | ↗ |
| 173 | 2005 | William P. Sullivan President and Chief Executive Officer | 783.3K | 773.1K | — | 149.0K | — | 8.4K | 1.56M | 9.52% | ↗ |
| 174 | 2005 | Adrian T. Dillon Executive Vice President, Finance and Administration, Chief Financial Officer | 650.0K | 459.6K | — | 80.0K | — | 8.4K | 1.12M | 7.16% | ↗ |
| 175 | 2005 | Thomas E. White Senior Vice President, Operations Support Systems Group | 503.0K | 270.0K | — | 32.0K | — | — | 773.0K | 4.14% | ↗ |
| 176 | 2005 | D. Craig Nordlund Senior Vice President, General Counsel and Secretary | 425.0K | 257.6K | — | 28.5K | — | 8.4K | 691.0K | 4.12% | ↗ |
| 177 | 2005 | Jean Halloran Senior Vice President, Human Resources | 400.0K | 242.4K | — | 25.5K | — | 8.4K | 650.8K | 3.92% | ↗ |
| 178 | 2005 | Christopher van Ingen Senior Vice President, Life Science and Chemical Analysis | 400.0K | 241.3K | — | 73.5K | — | 8.4K | 649.7K | 11.31% | ↗ |
| 179 | 2005 | Patrick J. Byrne Senior Vice President, Electronics Measurement Group | 379.3K | 249.8K | — | 48.0K | — | 8.4K | 637.4K | 7.53% | ↗ |
| 180 | 2004 | Edward W. Barnholt Former President and Chief Executive Officer | 1.00M | 1.50M | — | 154.0K | — | 8.2K | 2.51M | 6.13% | ↗ |
| 181 | 2004 | Edward W. Barnholt Chief Executive Officer | 1.00M | 1.50M | — | 154.0K | — | 8.2K | 2.51M | 6.13% | ↗ |
| 182 | 2004 | William P. Sullivan Executive Vice President Chief Operating Officer | 637.5K | 601.6K | — | 85.0K | — | 8.2K | 1.25M | 6.81% | ↗ |
| 183 | 2004 | William P. Sullivan President and Chief Executive Officer | 637.5K | 601.6K | — | 85.0K | — | 8.2K | 1.25M | 6.81% | ↗ |
| 184 | 2004 | Adrian T. Dillon Executive Vice President, Finance and Administration, Chief Financial Officer | 650.0K | 526.4K | — | 54.0K | — | 8.2K | 1.18M | 4.56% | ↗ |
| 185 | 2004 | Adrian Dillon Executive Vice President Chief Financial Officer | 650.0K | 526.4K | — | 54.0K | — | 8.2K | 1.18M | 4.56% | ↗ |
| 186 | 2004 | Young K. Sohn Senior Vice President Semiconductor Products | 425.0K | 311.5K | — | — | — | 8.2K | 744.7K | 0.00% | ↗ |
| 187 | 2004 | Christopher van Ingen Senior Vice President, Life Science and Chemical Analysis | 396.3K | 333.1K | — | 40.0K | — | 8.2K | 737.6K | 5.42% | ↗ |
| 188 | 2004 | Chris van Ingen Senior Vice President Life Science and Chemical Analysis | 396.3K | 333.1K | — | 40.0K | — | 8.2K | 737.6K | 5.42% | ↗ |
| 189 | 2004 | Thomas E. White Senior Vice President, Operations Support Systems Group | 455.0K | 265.9K | — | 29.0K | — | — | 720.9K | 4.02% | ↗ |
| 190 | 2004 | D. Craig Nordlund Senior Vice President, General Counsel and Secretary | 425.0K | 245.8K | — | 23.0K | — | 8.2K | 679.0K | 3.39% | ↗ |
| 191 | 2004 | Jean Halloran Senior Vice President, Human Resources | 400.0K | 231.4K | — | 23.0K | — | 8.2K | 639.6K | 3.60% | ↗ |
| 192 | 2004 | Patrick J. Byrne Senior Vice President, Electronics Measurement Group | 347.0K | 189.3K | — | 75.0K | — | 8.2K | 544.5K | 13.77% | ↗ |
| 193 | 2003 | Edward W. Barnholt Chairman of the Board, President and Chief Executive Officer | 1.00M | 333.5K | — | 600.0K | — | 8.0K | 1.34M | 44.73% | ↗ |
| 194 | 2003 | Edward W. Barnholt Former President and Chief Executive Officer | 1.00M | 333.5K | — | 600.0K | — | 8.0K | 1.34M | 44.73% | ↗ |
| 195 | 2003 | Edward W. Barnholt Chief Executive Officer | 1.00M | 333.5K | — | 600.0K | — | 8.0K | 1.34M | 44.73% | ↗ |
| 196 | 2003 | Young K. Sohn Senior Vice President Semiconductor Products | 92.7K | — | 1.24M | 175.0K | — | 1.2K | 1.33M | 106.09% | ↗ |
| 197 | 2003 | Adrian T. Dillon Executive Vice President, Finance and Administration, Chief Financial Officer | 650.0K | 116.7K | — | 250.0K | — | 8.0K | 774.7K | 32.27% | ↗ |
| 198 | 2003 | Adrian T. Dillon Executive Vice President, Chief Financial Officer | 650.0K | 116.7K | — | 250.0K | — | 8.0K | 774.7K | 32.27% | ↗ |
| 199 | 2003 | Adrian Dillon Executive Vice President Chief Financial Officer | 650.0K | 116.7K | — | 250.0K | — | 8.0K | 774.7K | 32.27% | ↗ |
| 200 | 2003 | William P. Sullivan President and Chief Executive Officer | 600.0K | 107.7K | — | 250.0K | — | 8.0K | 715.7K | 34.93% | ↗ |
| 201 | 2003 | William P. Sullivan Executive Vice President Chief Operating Officer | 600.0K | 107.7K | — | 250.0K | — | 8.0K | 715.7K | 34.93% | ↗ |
| 202 | 2003 | William P. Sullivan Executive Vice President, Chief Operating Officer | 600.0K | 107.7K | — | 250.0K | — | 8.0K | 715.7K | 34.93% | ↗ |
| 203 | 2003 | Byron J. Anderson Senior Vice President, Electronic Products and Solutions | 525.0K | 16.2K | — | 125.0K | — | 8.0K | 549.2K | 22.76% | ↗ |
| 204 | 2003 | Chris van Ingen Senior Vice President Life Science and Chemical Analysis | 374.8K | 121.5K | — | 125.0K | — | 8.0K | 504.3K | 24.79% | ↗ |
| 205 | 2003 | Chris van Ingen Senior Vice President, Life Science and Chemical Analysis | 374.8K | 121.5K | — | 125.0K | — | 8.0K | 504.3K | 24.79% | ↗ |
| 206 | 2003 | D. Craig Nordlund Senior Vice President, General Counsel and Secretary | 425.0K | 54.5K | — | 100.0K | — | 8.0K | 487.5K | 20.51% | ↗ |
| 207 | 2003 | Jean Halloran Senior Vice President, Human Resources | 400.0K | 51.3K | — | 100.0K | — | 8.0K | 459.3K | 21.77% | ↗ |
| 208 | 2003 | Thomas E. White Senior Vice President, Operations Support Systems Group | 430.6K | 17.9K | — | 70.0K | — | — | 448.5K | 15.61% | ↗ |
| 209 | 2002 | Adrian T. Dillon Executive Vice President, Chief Financial Officer | 552.5K | 650.0K | 1.37M | 200.0K | — | 5.1K | 2.57M | 60.83% | ↗ |
| 210 | 2002 | Adrian T. Dillon Executive Vice President, Chief Financial Officer | 552.5K | 650.0K | 1.37M | — | — | 5.1K | 2.57M | 53.06% | ↗ |
| 211 | 2002 | Adrian Dillon Executive Vice President Chief Financial Officer | 552.5K | 650.0K | 1.37M | 200.0K | — | 5.1K | 2.57M | 60.83% | ↗ |
| 212 | 2002 | Edward W. Barnholt Chief Executive Officer | 925.0K | — | — | 750.0K | — | 8.0K | 933.0K | 80.39% | ↗ |
| 213 | 2002 | Edward W. Barnholt Chairman of the Board, President and Chief | 925.0K | — | — | — | — | 8.0K | 933.0K | 0.00% | ↗ |
| 214 | 2002 | Edward W. Barnholt Chairman of the Board, President and Chief Executive Officer | 925.0K | — | — | 750.0K | — | 8.0K | 933.0K | 80.39% | ↗ |
| 215 | 2002 | John E. Scruggs Senior Vice President, Automated Test | 462.5K | 135.6K | — | — | — | 8.0K | 606.1K | 0.00% | ↗ |
| 216 | 2002 | William P. Sullivan Executive Vice President, Chief Operating Officer | 532.5K | — | — | 300.0K | — | 3.6K | 536.1K | 55.96% | ↗ |
| 217 | 2002 | William P. Sullivan Executive Vice President Chief Operating Officer | 532.5K | — | — | 300.0K | — | 3.6K | 536.1K | 55.96% | ↗ |
| 218 | 2002 | William P. Sullivan Executive Vice President, Chief Operating Officer | 532.5K | — | — | — | — | 3.6K | 536.1K | 0.00% | ↗ |
| 219 | 2002 | Byron J. Anderson Senior Vice President, Electronic Products and | 485.6K | — | — | — | — | 8.0K | 493.6K | 0.00% | ↗ |
| 220 | 2002 | Byron J. Anderson Senior Vice President, Electronic Products and Solutions | 485.6K | — | — | 175.0K | — | 8.0K | 493.6K | 35.45% | ↗ |
| 221 | 2002 | Jack P. Trautman Senior Vice President, Automated Test | 367.4K | 67.1K | — | — | — | 472.00 | 435.0K | 0.00% | ↗ |
| 222 | 2002 | D. Craig Nordlund Senior Vice President, General Counsel and Secretary | 393.1K | — | — | 100.0K | — | 8.0K | 401.1K | 24.93% | ↗ |
| 223 | 2002 | Chris van Ingen Senior Vice President, Life Science and Chemical Analysis | 323.8K | 42.9K | — | 125.0K | — | 8.0K | 374.6K | 33.37% | ↗ |
| 224 | 2002 | Chris van Ingen Senior Vice President Life Science and Chemical Analysis | 323.8K | 42.9K | — | 125.0K | — | 8.0K | 374.6K | 33.37% | ↗ |
| 225 | 2002 | Young K. Sohn Senior Vice President Semiconductor Products | — | — | — | — | — | — | — | — | ↗ |
| 226 | 2001 | Edward W. Barnholt President and Chief Executive Officer | 941.7K | — | — | — | — | 6.8K | 948.5K | 0.00% | ↗ |
| 227 | 2001 | Edward W. Barnholt Chairman of the Board, President and Chief | 941.7K | — | — | — | — | 6.8K | 948.5K | 0.00% | ↗ |
| 228 | 2001 | Edward W. Barnholt Chairman of the Board, President and Chief Executive Officer | 941.7K | — | — | 500.0K | — | 6.8K | 948.5K | 52.72% | ↗ |
| 229 | 2001 | Alain A. Couder Executive Vice President and Chief Operating Officer | 668.8K | — | — | — | — | 5.1K | 673.9K | 0.00% | ↗ |
| 230 | 2001 | Byron J. Anderson Senior Vice President, Electronic Products and Solutions | 488.1K | — | — | 75.0K | — | 6.8K | 494.9K | 15.15% | ↗ |
| 231 | 2001 | Byron J. Anderson Senior Vice President, Electronic Products and | 488.1K | — | — | — | — | 6.8K | 494.9K | 0.00% | ↗ |
| 232 | 2001 | Byron Anderson Senior Vice President, Electronic Products and Solutions | 488.1K | — | — | — | — | 6.8K | 494.9K | 0.00% | ↗ |
| 233 | 2001 | William P. Sullivan Executive Vice President, Chief Operating Officer | 473.1K | — | — | 200.0K | — | 6.8K | 479.9K | 41.67% | ↗ |
| 234 | 2001 | William P. Sullivan Senior Vice President, Semiconductor Products | 473.1K | — | — | — | — | 6.8K | 479.9K | 0.00% | ↗ |
| 235 | 2001 | William P. Sullivan Executive Vice President, Chief Operating Officer | 473.1K | — | — | — | — | 6.8K | 479.9K | 0.00% | ↗ |
| 236 | 2001 | John E. Scruggs Senior Vice President, Automated Test | 463.3K | — | — | — | — | 6.8K | 470.1K | 0.00% | ↗ |
| 237 | 2001 | D. Craig Nordlund Senior Vice President, General Counsel and Secretary | 392.0K | — | — | 150.0K | — | 6.8K | 398.8K | 37.62% | ↗ |
| 238 | 2001 | Chris van Ingen Senior Vice President, Life Science and Chemical Analysis | 329.6K | — | — | 125.0K | — | 6.8K | 336.4K | 37.16% | ↗ |
| 239 | 2001 | Adrian T. Dillon Executive Vice President, Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 240 | 2001 | Jack P. Trautman Senior Vice President, Automated Test | — | — | — | — | — | — | — | — | ↗ |
| 241 | 2001 | Adrian T. Dillon Executive Vice President, Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 242 | 2000 | Edward W. Barnholt Chairman of the Board, President and Chief | 1.00M | 660.0K | 46.9K | — | — | 6.8K | 1.71M | 2.74% | ↗ |
| 243 | 2000 | Edward W. Barnholt President and Chief Executive Officer | 1.00M | 660.0K | 46.9K | — | — | 6.8K | 1.71M | 2.74% | ↗ |
| 244 | 2000 | John E. Scruggs Senior Vice President, Automated Test | 470.0K | 243.9K | 19.8K | — | — | 6.8K | 740.5K | 2.67% | ↗ |
| 245 | 2000 | Byron J. Anderson Senior Vice President, Electronic Products and | 500.0K | 173.7K | 21.3K | — | — | 6.8K | 701.8K | 3.04% | ↗ |
| 246 | 2000 | Byron Anderson Senior Vice President, Electronic Products and Solutions | 500.0K | 173.7K | 21.3K | — | — | 6.8K | 701.8K | 3.04% | ↗ |
| 247 | 2000 | William P. Sullivan Executive Vice President, Chief Operating Officer | 440.0K | 205.3K | — | — | — | 7.3K | 652.6K | 0.00% | ↗ |
| 248 | 2000 | William P. Sullivan Senior Vice President, Semiconductor Products | 440.0K | 205.3K | — | — | — | 7.3K | 652.6K | 0.00% | ↗ |
| 249 | 2000 | Alain A. Couder Executive Vice President and Chief Operating Officer | 427.3K | 85.5K | — | — | — | 5.1K | 517.9K | 0.00% | ↗ |
| 250 | 2000 | Adrian T. Dillon Executive Vice President, Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 251 | 2000 | Jack P. Trautman Senior Vice President, Automated Test | — | — | — | — | — | — | — | — | ↗ |
| 252 | 1999 | Edward W. Barnholt President and Chief Executive Officer | 920.6K | 474.7K | 409.1K | — | — | 313.9K | 2.12M | 19.31% | ↗ |
| 253 | 1999 | William P. Sullivan Senior Vice President, Semiconductor Products | 408.4K | 174.3K | 177.6K | — | — | 30.7K | 791.0K | 22.45% | ↗ |
| 254 | 1999 | John E. Scruggs Senior Vice President, Automated Test | 415.2K | 193.4K | 21.2K | — | — | 80.1K | 709.8K | 2.98% | ↗ |
| 255 | 1999 | Byron Anderson Senior Vice President, Electronic Products and Solutions | 425.0K | 135.7K | 22.9K | — | — | 109.5K | 693.1K | 3.31% | ↗ |
| 256 | 1999 | Alain A. Couder Executive Vice President and Chief Operating Officer | — | — | — | — | — | — | — | — | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Padraig McDonnell | Chief Executive Officer, President & Director | 3M | male |
| Simon May | Senior VP and President of Life Sciences & Diagnostics Markets Group | 2M | — |
| Bret DiMarco | Senior VP & Secretary | 1M | male |
| Angelica Riemann | Senior VP & President of Agilent CrossLab Group | 1M | female |
| Rodney Gonsalves | Principal Accounting Officer, Vice President & Corporate Controller | 832.1K | male |
| Adam S. Elinoff | Senior Vice President, Chief Financial Officer & Principal Financial Officer | — | male |
| Tejas Rajeev Savant | Vice President of Investor Relations | — | male |
| August Specht | Senior Vice President & Chief Technology Officer | — | male |
| Frederick Schwarz | Senior VP, Chief Strategy & Corporate Development Officer | — | male |
| Meghan A. Henson | Senior Vice President & Chief Human Resources Officer | — | female |
| Michael Buckner | Senior VP & Chief Legal Officer | — | male |
| Transaction Date | Disclosed | Senator | State | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2024-05-03 | 2024-06-14 | Tommy Tuberville | AL | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2024-04-05 | 2024-05-15 | Tommy Tuberville | AL | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2023-10-16 | 2023-11-16 | Tommy Tuberville | AL | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2023-04-03 | 2023-05-12 | Tommy Tuberville | AL | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2022-04-03 | 2023-05-11 | Tommy Tuberville | AL | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2016-09-13 | 2016-10-20 | James Inhofe | OK | Self | Sale (Full) | $50,001 - $100,000 | ↗ |
| 2015-08-24 | 2015-09-10 | James Inhofe | OK | Self | Purchase | $15,001 - $50,000 | ↗ |
| 2015-02-24 | 2015-03-17 | Sheldon Whitehouse | RI | Self | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2014-10-02 | 2014-10-28 | Sheldon Whitehouse | RI | Self | Purchase | $1,001 - $15,000 | ↗ |
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-09-29 | 2025-10-03 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-07-16 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2025-07-16 | 2025-08-14 | Lisa McClain | MI09 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2025-06-17 | 2025-08-14 | Lisa McClain | MI09 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2025-05-15 | 2025-06-02 | Rob Bresnahan | PA08 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-05-12 | 2025-06-23 | Jefferson Shreve | IN06 | — | Sale | $15,001 - $50,000 | ↗ |
| 2025-04-17 | 2025-05-09 | Jefferson Shreve | IN06 | — | Purchase | $15,001 - $50,000 | ↗ |
| 2025-04-08 | 2025-04-29 | Rob Bresnahan | PA08 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-04-01 | 2025-05-15 | Julie Johnson | TX32 | Joint | Sale | $1,001 - $15,000 | ↗ |
| 2025-03-13 | 2025-04-14 | Jefferson Shreve | IN06 | — | Sale | $15,001 - $50,000 | ↗ |
| 2025-03-03 | 2025-04-15 | Julie Johnson | TX32 | — | Sale | $1,001 - $15,000 | ↗ |
| 2024-10-14 | 2024-11-11 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-11-03 | 2023-12-06 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-10-31 | 2023-11-08 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2023-10-02 | 2023-11-08 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2023-06-29 | 2023-07-11 | Ro Khanna | CA17 | Spouse | Sale | $15,001 - $50,000 | ↗ |
| 2023-06-26 | 2023-07-11 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2023-05-23 | 2023-06-12 | Ro Khanna | CA17 | — | Sale | $15,001 - $50,000 | ↗ |
| 2022-06-16 | 2022-07-07 | Ro Khanna | CA17 | Spouse | Purchase | $15,001 - $50,000 | ↗ |
| 2022-05-10 | 2022-06-10 | Ro Khanna | CA17 | — | Purchase | $15,001 - $50,000 | ↗ |
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for A
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
